RxNorm Semantic Concepts Index - 260
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "260".
| RxCUI | Name | Term Type | Term Type Description | Is Prescribable? |
|---|---|---|---|---|
| RxCUI: 26000 | Glycerophosphocholine phosphodiesterase | Designated preferred name (PT) | NO | |
| RxCUI: 26000 | Glycerophosphocholine phosphodiesterase | Full form of descriptor (FN) | NO | |
| RxCUI: 2600001 | cefadroxil Oral Suspension [Ultracef] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 260001 | folic acid 5 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 260001 | folic acid 5 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 260001 | folic acid 5 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 260002 | folic acid 20 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 260002 | folic acid 20 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 260002 | folic acid 20 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2600046 | diclofenac / lidocaine | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| RxCUI: 2600047 | diclofenac / lidocaine Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2600048 | diclofenac / lidocaine Topical Gel | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2600049 | diclofenac sodium 1 % / lidocaine HCl 4.5 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2600049 | diclofenac sodium 1 % / lidocaine HCl 4.5 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2600049 | diclofenac sodium 1 % / lidocaine HCl 4.5 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 260005 | talc 81 % / zinc oxide 15 % Topical Powder | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 260005 | talc 81 % / zinc oxide 15 % Topical Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 260005 | talc 81 % / zinc oxide 15 % Topical Powder | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 260005 | talc 81 % / zinc oxide 15 % Topical Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2600050 | Bacillus clausii | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 260006 | urea 10 % Medicated Shampoo | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 260006 | urea 10 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 260006 | urea 10 % Medicated Shampoo | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 26001 | Glycerophosphoryl diester phosphodiesterase | Designated preferred name (PT) | NO | |
| RxCUI: 26001 | Glycerophosphoryl diester phosphodiesterase | Full form of descriptor (FN) | NO | |
| RxCUI: 26001 | Glycerophosphoryl diester phosphodiesterase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 260011 | chlorpheniramine maleate 0.4 MG/mL / phenylephrine HCl 2 MG/mL / phenylpropanolamine HCl 2 MG/mL / pyrilamine maleate 2 MG/mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 260011 | chlorpheniramine maleate 0.4 MG/mL / phenylephrine HCl 2 MG/mL / phenylpropanolamine HCl 2 MG/mL / pyrilamine maleate 2 MG/mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 260011 | chlorpheniramine maleate 0.4 MG/mL / phenylephrine HCl 2 MG/mL / phenylpropanolamine HCl 2 MG/mL / pyrilamine maleate 2 MG/mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 260012 | willow bark extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 260012 | willow bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 260012 | willow bark extract | Designated preferred name (PT) | YES | |
| RxCUI: 260012 | willow bark extract | Full form of descriptor (FN) | YES | |
| RxCUI: 260012 | willow bark extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 260014 | watermelon preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2600180 | Beclometasone dipropionate 10 mg oral tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2600180 | Beclometasone dipropionate 10 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2600180 | Beclometasone dipropionate 10 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 260020 | horse chestnut seed | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 260025 | Brauneria purpurea extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 260025 | Brauneria purpurea extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 260025 | Brauneria purpurea extract | Designated preferred name (PT) | YES | |
| RxCUI: 260025 | Brauneria purpurea extract | Full form of descriptor (FN) | YES | |
| RxCUI: 260025 | Brauneria purpurea extract | Full form of descriptor (FN) | YES | |
| RxCUI: 260025 | Brauneria purpurea extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2600295 | amantadine 161 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2600296 | amantadine 161 MG 24HR Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2600296 | amantadine 161 MG 24HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2600297 | amantadine 161 MG Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2600297 | amantadine 161 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2600298 | amantadine 161 MG [Osmolex] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2600299 | Osmolex 161 MG 24HR Extended Release Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2600299 | Osmolex 161 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2600299 | Osmolex 161 MG 24HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2600299 | Osmolex 161 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2600300 | Osmolex 161 MG Extended Release Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2600300 | Osmolex 161 MG Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2600300 | Osmolex 161 MG Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2600301 | lidocaine HCl 4 % / menthol 5 % Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2600301 | lidocaine HCl 4 % / menthol 5 % Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2600301 | lidocaine HCl 4 % / menthol 5 % Medicated Patch | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2600348 | sodium chloride 9 MG/ML [Aqua Maris] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2600349 | AQUA MARIS Baby 0.9 % Nasal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2600349 | AQUA MARIS Baby 0.9 % Nasal Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2600349 | AQUA MARIS Baby 0.9 % Nasal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2600349 | AQUA MARIS Baby 0.9 % Nasal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2600349 | AQUA MARIS Baby 0.9 % Nasal Spray | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2600350 | isopropyl alcohol 50 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2600350 | isopropyl alcohol 50 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2600350 | isopropyl alcohol 50 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2600351 | calcium fructoborate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 260036 | Cevimeline hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 260036 | Cevimeline hydrochloride | Designated preferred name (PT) | YES | |
| RxCUI: 260036 | Cevimeline hydrochloride | Full form of descriptor (FN) | YES | |
| RxCUI: 260038 | Korean ginseng root | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 260039 | sangre de grado | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 260039 | sangre de grado | Designated preferred name (PT) | NO | |
| RxCUI: 260039 | sangre de grado | Full form of descriptor (FN) | NO | |
| RxCUI: 260040 | Oenothera biennis whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 260040 | Oenothera biennis whole extract | Designated preferred name (PT) | YES | |
| RxCUI: 260040 | Oenothera biennis whole extract | Full form of descriptor (FN) | YES | |
| RxCUI: 260040 | Oenothera biennis whole extract | Designated preferred name (PT) | YES | |
| RxCUI: 260040 | Oenothera biennis whole extract | Full form of descriptor (FN) | YES | |
| RxCUI: 260040 | Oenothera biennis whole extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 260051 | wasp venom protein | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 260053 | elderberry fruit | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 260054 | triclosan 0.3 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 260054 | triclosan 0.3 % Medicated Liquid Soap | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 260054 | triclosan 0.3 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 260054 | triclosan 0.3 % Medicated Liquid Soap | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 260055 | kava root 100 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 260063 | guaifenesin 200 MG / theophylline 150 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 260063 | guaifenesin 200 MG / theophylline 150 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 260066 | methylcellulose 133.3 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 26007 | GMTG - Glyceryl monothioglycolate | Designated preferred name (PT) | NO | |
| RxCUI: 26007 | GMTG - Glyceryl monothioglycolate | Full form of descriptor (FN) | NO | |
| RxCUI: 26007 | GMTG - Glyceryl monothioglycolate | Designated preferred name (PT) | NO | |
| RxCUI: 26007 | GMTG - Glyceryl monothioglycolate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 26007 | GMTG - Glyceryl monothioglycolate | Full form of descriptor (FN) | NO | |
| RxCUI: 260076 | calcium phosphate 250 MG / gamboge 115 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 260077 | ginger root 470 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2600775 | bismuth phosphate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2600776 | cadmium fluoride | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2600777 | isomaltitol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2600779 | imepitoin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2600781 | magnesium carbonate 10.8 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2600782 | magnesium carbonate 54 MG in 5 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2600782 | magnesium carbonate 54 MG in 5 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2600782 | magnesium carbonate 54 MG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2600783 | Magonate Reformulated May 2022 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2600784 | magnesium carbonate 10.8 MG/ML [Magonate Reformulated May 2022] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2600785 | Magonate Reformulated May 2022 Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2600786 | Magonate Reformulated May 2022 Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2600787 | magnesium carbonate Oral Solution [Magonate Reformulated May 2022] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2600788 | Magonate 54 MG in 5 mL Oral Solution, Reformulated May 2022 | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2600788 | Magonate 54 MG in 5 mL Oral Solution, Reformulated May 2022 | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2600788 | Magonate 54 MG in 5 mL Oral Solution, Reformulated May 2022 | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2600788 | Magonate 54 MG in 5 mL Oral Solution, Reformulated May 2022 | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 260079 | vit-C 50 MG / Pantothenic Acid 125 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 260079 | vit-C 50 MG / Pantothenic Acid 125 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 260079 | vit-C 50 MG / Pantothenic Acid 125 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 260080 | calcium carbonate 265 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 260084 | horse chestnut seed 300 MG 12 HR Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 260084 | horse chestnut seed 300 MG 12 HR Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 260086 | melatonin 3 MG / pyridoxine HCl 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 260086 | melatonin 3 MG / pyridoxine HCl 10 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2600867 | mavacamten | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2600868 | mavacamten 10 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2600869 | mavacamten Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2600870 | mavacamten Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2600871 | mavacamten Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2600872 | mavacamten 10 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2600872 | mavacamten 10 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2600873 | Camzyos | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2600874 | mavacamten 10 MG [Camzyos] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2600875 | Camzyos Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2600876 | Camzyos Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2600877 | mavacamten Oral Capsule [Camzyos] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2600878 | CAMZYOS 10 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2600878 | CAMZYOS 10 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2600878 | CAMZYOS 10 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2600879 | mavacamten 15 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 260088 | carbetapentane tannate 12 MG / chlorpheniramine tannate 1.6 MG/ML / phenylephrine tannate 2 MG/ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2600880 | mavacamten 15 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2600880 | mavacamten 15 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2600881 | mavacamten 15 MG [Camzyos] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2600882 | CAMZYOS 15 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2600882 | CAMZYOS 15 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2600882 | CAMZYOS 15 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2600883 | mavacamten 2.5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2600884 | mavacamten 2.5 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2600884 | mavacamten 2.5 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2600885 | mavacamten 2.5 MG [Camzyos] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2600886 | CAMZYOS 2.5 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2600886 | CAMZYOS 2.5 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2600886 | CAMZYOS 2.5 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2600887 | mavacamten 5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2600888 | mavacamten 5 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2600888 | mavacamten 5 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2600889 | mavacamten 5 MG [Camzyos] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2600890 | CAMZYOS 5 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2600890 | CAMZYOS 5 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2600890 | CAMZYOS 5 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2600910 | camphor 6 % / menthol 4 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2600910 | camphor 6 % / menthol 4 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2600915 | potassium citrate 0.0553 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2600916 | sodium fluoride 0.0032 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2600917 | potassium citrate / sodium fluoride | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| RxCUI: 2600918 | potassium citrate / sodium fluoride Dental Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 2600919 | potassium citrate / sodium fluoride Paste Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 260092 | sangre de grado 350 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 260092 | sangre de grado 350 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2600920 | potassium citrate / sodium fluoride Oral Paste Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 2600921 | potassium citrate / sodium fluoride Toothpaste Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 2600922 | potassium citrate / sodium fluoride Toothpaste | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2600923 | potassium citrate 5.53 % / sodium fluoride 0.32 % Toothpaste | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2600923 | potassium citrate 5.53 % / sodium fluoride 0.32 % Toothpaste | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2600923 | potassium citrate 5.53 % / sodium fluoride 0.32 % Toothpaste | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2600923 | potassium citrate 5.53 % / sodium fluoride 0.32 % Toothpaste | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2600923 | potassium citrate 5.53 % / sodium fluoride 0.32 % Toothpaste | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2600924 | sodium chloride 10.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2600925 | sodium chloride 10.5 MG/ML Nasal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2600925 | sodium chloride 10.5 MG/ML Nasal Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2600925 | sodium chloride 10.5 MG/ML Nasal Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2600926 | sodium chloride 10.5 MG/ML [Aqua Maris] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2600927 | Aqua Maris Classic 10.5 MG/ML Nasal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2600927 | Aqua Maris Classic 10.5 MG/ML Nasal Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2600927 | Aqua Maris Classic 10.5 MG/ML Nasal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2600927 | Aqua Maris Classic 10.5 MG/ML Nasal Spray | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2600965 | Epsolay | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2600966 | benzoyl peroxide 50 MG/ML [Epsolay] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2600967 | Epsolay Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2600968 | benzoyl peroxide Topical Cream [Epsolay] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2600969 | EPSOLAY 5 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2600969 | EPSOLAY 5 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2600969 | EPSOLAY 5 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2600969 | EPSOLAY 5 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2601 | clonixin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 26010 | Glyceryl-ether cleaving enzyme | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 26010 | Glyceryl-ether cleaving enzyme | Designated preferred name (PT) | NO | |
| RxCUI: 26010 | Glyceryl-ether cleaving enzyme | Full form of descriptor (FN) | NO | |
| RxCUI: 260101 | Oseltamivir | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 260101 | Oseltamivir | Designated preferred name (PT) | YES | |
| RxCUI: 260101 | Oseltamivir | Full form of descriptor (FN) | YES | |
| RxCUI: 260101 | Oseltamivir | Designated preferred name (PT) | YES | |
| RxCUI: 260101 | Oseltamivir | Full form of descriptor (FN) | YES | |
| RxCUI: 260107 | vitamin E 90 MG (200 UNT) Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 260107 | vitamin E 90 MG (200 UNT) Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 260107 | vitamin E 90 MG (200 UNT) Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2601096 | calamine 3.5 % / menthol 0.2 % / petrolatum 69 % / zinc oxide 20 % Topical Paste | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2601096 | calamine 3.5 % / menthol 0.2 % / petrolatum 69 % / zinc oxide 20 % Topical Paste | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2601096 | calamine 3.5 % / menthol 0.2 % / petrolatum 69 % / zinc oxide 20 % Topical Paste | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2601096 | calamine 3.5 % / menthol 0.2 % / petrolatum 69 % / zinc oxide 20 % Topical Paste | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2601097 | calcium carbonate 200 MG / magnesium carbonate 400 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2601097 | calcium carbonate 200 MG / magnesium carbonate 400 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2601097 | calcium carbonate 200 MG / magnesium carbonate 400 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2601098 | Commiphora wightii resin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2601099 | Gaultheria procumbens whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2601100 | PEG-6 sorbitan stearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2601101 | Triluron | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2601102 | sodium hyaluronate 10 MG/ML [Triluron] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2601103 | Triluron Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2601104 | hyaluronate Prefilled Syringe [Triluron] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2601105 | Triluron 20 MG in 2 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2601105 | Triluron 20 MG in 2 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2601105 | Triluron 20 MG in 2 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2601105 | Triluron 20 MG in 2 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2601106 | Triluron 10 MG/ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2601106 | Triluron 10 MG/ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2601106 | Triluron 10 MG/ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2601108 | trachyspermum ammi flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2601109 | Vitex negundo whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2601115 | dexmedetomidine 0.12 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2601115 | dexmedetomidine 0.12 MG | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2601116 | dexmedetomidine Sublingual Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2601116 | dexmedetomidine Sublingual Product | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2601117 | dexmedetomidine Oral Film Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2601117 | dexmedetomidine Oral Film Product | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2601118 | dexmedetomidine Sublingual Film | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2601118 | dexmedetomidine Sublingual Film | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2601119 | dexmedeTOMIDine 120 MCG Sublingual Film | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2601119 | dexmedeTOMIDine 120 MCG Sublingual Film | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2601119 | dexmedeTOMIDine 120 MCG Sublingual Film | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2601119 | dexmedeTOMIDine 120 MCG Sublingual Film | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2601119 | dexmedeTOMIDine 120 MCG Sublingual Film | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2601120 | Igalmi | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2601121 | dexmedetomidine 0.12 MG [Igalmi] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2601121 | dexmedetomidine 0.12 MG [Igalmi] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2601122 | Igalmi Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2601123 | Igalmi Sublingual Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2601124 | Igalmi Oral Film Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2601125 | dexmedetomidine Sublingual Film [Igalmi] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2601125 | dexmedetomidine Sublingual Film [Igalmi] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2601126 | Igalmi 120 MCG Sublingual Film | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2601126 | Igalmi 120 MCG Sublingual Film | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2601126 | Igalmi 120 MCG Sublingual Film | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2601126 | Igalmi 120 MCG Sublingual Film | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2601126 | Igalmi 120 MCG Sublingual Film | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2601128 | dexmedetomidine 0.18 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2601128 | dexmedetomidine 0.18 MG | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2601129 | dexmedeTOMIDine 180 MCG Sublingual Film | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2601129 | dexmedeTOMIDine 180 MCG Sublingual Film | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2601129 | dexmedeTOMIDine 180 MCG Sublingual Film | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2601129 | dexmedeTOMIDine 180 MCG Sublingual Film | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2601129 | dexmedeTOMIDine 180 MCG Sublingual Film | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2601130 | dexmedetomidine 0.18 MG [Igalmi] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2601130 | dexmedetomidine 0.18 MG [Igalmi] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2601131 | Igalmi 180 MCG Sublingual Film | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2601131 | Igalmi 180 MCG Sublingual Film | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2601131 | Igalmi 180 MCG Sublingual Film | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2601131 | Igalmi 180 MCG Sublingual Film | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2601131 | Igalmi 180 MCG Sublingual Film | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 260117 | chitosan 500 MG / chromium picolinate 0.05 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 260121 | kava root 233 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 260121 | kava root 233 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 260122 | diphtheria toxoid vaccine, inactivated 0.036 MG/ML / Haemophilus capsular oligosaccharide 0.05 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 260123 | Haemophilus capsular oligosaccharide 0.02 MG/ML / tetanus toxoid vaccine, inactivated 0.048 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 260125 | prednisolone 25 MG/ML Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 260125 | prednisolone 25 MG/ML Injectable Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 260125 | prednisolone 25 MG/ML Injectable Suspension | Designated preferred name (PT) | NO | |
| RxCUI: 260125 | prednisolone 25 MG/ML Injectable Suspension | Full form of descriptor (FN) | NO | |
| RxCUI: 260127 | prednisolone 50 MG/ML Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 260127 | prednisolone 50 MG/ML Injectable Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2601304 | frunevetmab | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2601307 | cholecalciferol 0.0625 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2601308 | cholecalciferol 62.5 MCG (2500 UNT) Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2601308 | cholecalciferol 62.5 MCG (2500 UNT) Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2601308 | cholecalciferol 62.5 MCG (2500 UNT) Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2601308 | cholecalciferol 62.5 MCG (2500 UNT) Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2601308 | cholecalciferol 62.5 MCG (2500 UNT) Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2601368 | petrolatum 0.934 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2601369 | petrolatum 93.4 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2601369 | petrolatum 93.4 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2601447 | calcium bromate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2601450 | menthol 0.2 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2601450 | menthol 0.2 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2601450 | menthol 0.2 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2601502 | Azaperone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2601502 | Azaperone | Designated preferred name (PT) | NO | |
| RxCUI: 2601502 | Azaperone | Full form of descriptor (FN) | NO | |
| RxCUI: 2601503 | hypromellose 2910 0.45% stearoxy ether | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2601541 | bortezomib 1 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2601542 | bortezomib 1 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2601542 | bortezomib 1 MG Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2601543 | bortezomib 2.5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2601544 | bortezomib 2.5 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2601544 | bortezomib 2.5 MG Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2601548 | Spikevax | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2601549 | SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 0.2 MG/ML [Spikevax] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2601550 | Spikevax Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2601551 | SARS-CoV-2 (COVID-19) vaccine, mRNA spike protein Injectable Suspension [Spikevax] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2601552 | Spikevax 0.2 MG/ML Injectable Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2601552 | Spikevax 0.2 MG/ML Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2601552 | Spikevax 0.2 MG/ML Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2601578 | epinephrine / lidocaine Rectal Spray | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2601578 | epinephrine / lidocaine Rectal Spray | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2601579 | EPINEPHrine HCl 0.01 % / lidocaine HCl 5 % Rectal Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2601579 | EPINEPHrine HCl 0.01 % / lidocaine HCl 5 % Rectal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2601579 | EPINEPHrine HCl 0.01 % / lidocaine HCl 5 % Rectal Spray | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2601579 | EPINEPHrine HCl 0.01 % / lidocaine HCl 5 % Rectal Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2601579 | EPINEPHrine HCl 0.01 % / lidocaine HCl 5 % Rectal Spray | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2601580 | menthol 27.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2601581 | menthol 2.75 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2601581 | menthol 2.75 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2601581 | menthol 2.75 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2601582 | medetomidine hydrochloride 0.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2601583 | vatinoxan hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 2601584 | vatinoxan | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2601585 | vatinoxan hydrochloride 10 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2601586 | medetomidine / vatinoxan | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| RxCUI: 2601587 | medetomidine / vatinoxan Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 2601588 | medetomidine / vatinoxan Injectable Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2601589 | medetomidine hydrochloride 0.5 MG/ML / vatinoxan hydrochloride 10 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2601589 | medetomidine hydrochloride 0.5 MG/ML / vatinoxan hydrochloride 10 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2601590 | Zenalpha | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2601591 | medetomidine hydrochloride 0.5 MG/ML / vatinoxan hydrochloride 10 MG/ML [Zenalpha] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2601592 | Zenalpha Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2601593 | medetomidine / vatinoxan Injectable Solution [Zenalpha] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2601594 | Zenalpha 0.5 MG / 10 MG in 1 ML Injectable Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2601594 | Zenalpha 0.5 MG / 10 MG in 1 ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2601594 | Zenalpha 0.5 MG / 10 MG in 1 ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2601595 | disodium glutamate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 2601715 | Phyllostachys nigra leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2601717 | zinc gluconate Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 2601718 | zinc gluconate Medicated Pad or Tape | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 2601719 | zinc gluconate Medicated Pad | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2601720 | zinc gluconate 1 % Medicated Pad | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2601720 | zinc gluconate 1 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2601720 | zinc gluconate 1 % Medicated Pad | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2601721 | water 970 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2601722 | water 97 % Ophthalmic Irrigation Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2601722 | water 97 % Ophthalmic Irrigation Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2601722 | water 97 % Ophthalmic Irrigation Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2601723 | tirzepatide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2601724 | baricitinib 4 MG [Olumiant] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2601725 | Olumiant 4 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2601725 | Olumiant 4 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2601725 | Olumiant 4 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2601727 | pemetrexed 1000 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2601727 | pemetrexed 1000 MG | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2601728 | PEMEtrexed 1 GM Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2601728 | PEMEtrexed 1 GM Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2601728 | PEMEtrexed 1 GM Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2601728 | PEMEtrexed 1 GM Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2601728 | PEMEtrexed 1 GM Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2601728 | PEMEtrexed 1 GM Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2601728 | PEMEtrexed 1 GM Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2601730 | tirzepatide Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2601731 | tirzepatide Auto-Injector | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2601734 | Mounjaro | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2601736 | Mounjaro Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2601737 | tirzepatide Auto-Injector [Mounjaro] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2601740 | zinc pyrithione 2.02 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2601741 | salicylic acid 0.2 % / zinc pyrithione 0.202 % Medicated Shampoo | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2601741 | salicylic acid 0.2 % / zinc pyrithione 0.202 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2601741 | salicylic acid 0.2 % / zinc pyrithione 0.202 % Medicated Shampoo | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2601742 | tirzepatide 10 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2601743 | tirzepatide 5 MG in 0.5 ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2601743 | tirzepatide 5 MG in 0.5 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2601743 | tirzepatide 5 MG in 0.5 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2601744 | tirzepatide 10 MG/ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2601745 | tirzepatide 10 MG/ML [Mounjaro] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2601746 | mounjaro 5 MG in 0.5 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2601746 | mounjaro 5 MG in 0.5 ML Auto-Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2601746 | mounjaro 5 MG in 0.5 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2601746 | mounjaro 5 MG in 0.5 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2601747 | tirzepatide 10 MG/ML Auto-Injector [Mounjaro] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2601747 | tirzepatide 10 MG/ML Auto-Injector [Mounjaro] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2601754 | tirzepatide 30 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2601755 | tirzepatide 15 MG in 0.5 ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2601755 | tirzepatide 15 MG in 0.5 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2601755 | tirzepatide 15 MG in 0.5 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2601756 | tirzepatide 30 MG/ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2601757 | tirzepatide 30 MG/ML [Mounjaro] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2601758 | mounjaro 15 MG in 0.5 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2601758 | mounjaro 15 MG in 0.5 ML Auto-Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2601758 | mounjaro 15 MG in 0.5 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2601758 | mounjaro 15 MG in 0.5 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2601759 | tirzepatide 30 MG/ML Auto-Injector [Mounjaro] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2601759 | tirzepatide 30 MG/ML Auto-Injector [Mounjaro] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2601760 | tirzepatide 5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2601761 | tirzepatide 2.5 MG in 0.5 ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2601761 | tirzepatide 2.5 MG in 0.5 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2601761 | tirzepatide 2.5 MG in 0.5 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2601762 | tirzepatide 5 MG/ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2601763 | tirzepatide 5 MG/ML [Mounjaro] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2601764 | mounjaro 2.5 MG in 0.5 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2601764 | mounjaro 2.5 MG in 0.5 ML Auto-Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2601764 | mounjaro 2.5 MG in 0.5 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2601764 | mounjaro 2.5 MG in 0.5 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2601765 | tirzepatide 5 MG/ML Auto-Injector [Mounjaro] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2601765 | tirzepatide 5 MG/ML Auto-Injector [Mounjaro] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2601766 | tirzepatide 20 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2601767 | tirzepatide 10 MG in 0.5 ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2601767 | tirzepatide 10 MG in 0.5 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2601767 | tirzepatide 10 MG in 0.5 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2601768 | tirzepatide 20 MG/ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2601769 | tirzepatide 20 MG/ML [Mounjaro] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2601770 | mounjaro 10 MG in 0.5 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2601770 | mounjaro 10 MG in 0.5 ML Auto-Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2601770 | mounjaro 10 MG in 0.5 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2601770 | mounjaro 10 MG in 0.5 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2601771 | tirzepatide 20 MG/ML Auto-Injector [Mounjaro] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2601771 | tirzepatide 20 MG/ML Auto-Injector [Mounjaro] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2601772 | tirzepatide 25 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2601773 | tirzepatide 12.5 MG in 0.5 ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2601773 | tirzepatide 12.5 MG in 0.5 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2601773 | tirzepatide 12.5 MG in 0.5 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2601774 | tirzepatide 25 MG/ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2601775 | tirzepatide 25 MG/ML [Mounjaro] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2601776 | mounjaro 12.5 MG in 0.5 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2601776 | mounjaro 12.5 MG in 0.5 ML Auto-Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2601776 | mounjaro 12.5 MG in 0.5 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2601776 | mounjaro 12.5 MG in 0.5 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2601777 | tirzepatide 25 MG/ML Auto-Injector [Mounjaro] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2601777 | tirzepatide 25 MG/ML Auto-Injector [Mounjaro] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2601778 | tirzepatide 15 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2601780 | tirzepatide 15 MG/ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2601781 | tirzepatide 15 MG/ML [Mounjaro] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2601783 | tirzepatide 15 MG/ML Auto-Injector [Mounjaro] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2601783 | tirzepatide 15 MG/ML Auto-Injector [Mounjaro] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2601784 | tirzepatide 7.5 MG in 0.5 ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2601784 | tirzepatide 7.5 MG in 0.5 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2601784 | tirzepatide 7.5 MG in 0.5 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2601785 | mounjaro 7.5 MG in 0.5 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2601785 | mounjaro 7.5 MG in 0.5 ML Auto-Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2601785 | mounjaro 7.5 MG in 0.5 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2601785 | mounjaro 7.5 MG in 0.5 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2601786 | frunevetmab 7 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2601787 | frunevetmab Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 2601788 | frunevetmab Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2601789 | frunevetmab 7 MG in 1 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2601789 | frunevetmab 7 MG in 1 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2601789 | frunevetmab 7 MG in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2601790 | frunevetmab 7 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2601791 | Solensia | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2601792 | frunevetmab 7 MG/ML [Solensia] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2601793 | Solensia Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2601794 | frunevetmab Injection [Solensia] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2601795 | Solensia 7 MG in 1 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2601795 | Solensia 7 MG in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2601795 | Solensia 7 MG in 1 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2601795 | Solensia 7 MG in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2601796 | frunevetmab 7 MG/ML Injection [Solensia] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2601796 | frunevetmab 7 MG/ML Injection [Solensia] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 260192 | hydrocortisone acetate 1 % Rectal Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 260192 | hydrocortisone acetate 1 % Rectal Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 260192 | hydrocortisone acetate 1 % Rectal Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 260208 | Haemophilus capsular oligosaccharide 0.03 MG/ML / Neisseria meningitidis 0.5 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 260209 | Haemophilus capsular oligosaccharide 0.015 MG/ML / Neisseria meningitidis 0.25 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 26021 | Glycine acetyltransferase | Designated preferred name (PT) | NO | |
| RxCUI: 26021 | Glycine acetyltransferase | Full form of descriptor (FN) | NO | |
| RxCUI: 2602113 | edaravone 21 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2602114 | edaravone Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2602115 | edaravone Oral Liquid Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2602116 | edaravone Oral Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2602117 | edaravone 21 MG/mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2602117 | edaravone 21 MG/mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2602117 | edaravone 21 MG/mL Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2602117 | edaravone 21 MG/mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2602118 | edaravone 21 MG/ML [Radicava] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2602119 | Radicava Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2602120 | Radicava Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2602121 | edaravone Oral Suspension [Radicava] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2602122 | Radicava ORS 21 MG/mL Oral Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2602122 | Radicava ORS 21 MG/mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2602122 | Radicava ORS 21 MG/mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2602122 | Radicava ORS 21 MG/mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2602122 | Radicava ORS 21 MG/mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2602123 | tecovirimat 10 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2602124 | tecovirimat Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2602125 | tecovirimat Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2602126 | tecovirimat 200 MG in 20 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2602126 | tecovirimat 200 MG in 20 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2602126 | tecovirimat 200 MG in 20 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2602127 | tecovirimat 10 MG/ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2602127 | tecovirimat 10 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2602128 | tecovirimat 10 MG/ML [Tpoxx] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2602129 | Tpoxx Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2602130 | tecovirimat Injection [Tpoxx] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2602131 | TPOXX 200 MG in 20 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2602131 | TPOXX 200 MG in 20 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2602131 | TPOXX 200 MG in 20 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2602131 | TPOXX 200 MG in 20 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2602132 | TPOXX 10 MG/ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2602132 | TPOXX 10 MG/ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2602132 | TPOXX 10 MG/ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2602133 | ethyl glycolate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2602134 | iscotrizinol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2602135 | pemetrexed 750 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2602135 | pemetrexed 750 MG | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2602136 | PEMEtrexed 750 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2602136 | PEMEtrexed 750 MG Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2602136 | PEMEtrexed 750 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2602136 | PEMEtrexed 750 MG Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2602136 | PEMEtrexed 750 MG Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2602137 | zinc gluconate Topical Spray | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2602138 | zinc gluconate 1 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2602138 | zinc gluconate 1 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2602138 | zinc gluconate 1 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2602140 | Allday | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2602141 | sodium fluoride 0.011 MG/MG [Allday] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2602142 | Allday Dental Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2602143 | Allday Paste Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2602144 | Allday Oral Paste Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2602145 | Allday Toothpaste Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2602146 | sodium fluoride Toothpaste [Allday] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2602147 | Allday 5000 1.1 % Toothpaste | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2602147 | Allday 5000 1.1 % Toothpaste | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2602147 | Allday 5000 1.1 % Toothpaste | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2602147 | Allday 5000 1.1 % Toothpaste | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 260218 | modafinil 100 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 260218 | modafinil 100 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 260218 | modafinil 100 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 260218 | modafinil 100 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 26022 | Glycine acyltransferase | Designated preferred name (PT) | NO | |
| RxCUI: 26022 | Glycine acyltransferase | Full form of descriptor (FN) | NO | |
| RxCUI: 260223 | hydroquinone 4 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 260223 | hydroquinone 4 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 260223 | hydroquinone 4 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 260225 | stannous fluoride 11 MG/mL Paste | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 260225 | stannous fluoride 11 MG/mL Paste | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2602275 | brolucizumab Prefilled Syringe | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2602276 | brolucizumab-dbll 6 MG in 0.05 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2602276 | brolucizumab-dbll 6 MG in 0.05 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2602276 | brolucizumab-dbll 6 MG in 0.05 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2602276 | brolucizumab-dbll 6 MG in 0.05 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2602277 | brolucizumab-dbll 120 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2602278 | brolucizumab Prefilled Syringe [Beovu] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2602279 | Beovu 6 MG in 0.05 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2602279 | Beovu 6 MG in 0.05 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2602279 | Beovu 6 MG in 0.05 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2602279 | Beovu 6 MG in 0.05 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2602280 | brolucizumab-dbll 120 MG/ML Prefilled Syringe [Beovu] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2602280 | brolucizumab-dbll 120 MG/ML Prefilled Syringe [Beovu] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2602282 | ceteth-18 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2602283 | Echinacea purpurea flowering top water | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2602284 | butyloctanol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2602285 | solanum anomalum whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2602286 | tapinarof | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2602288 | Differin Acne Clearing | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2602289 | salicylic acid 20 MG/ML [Differin Acne Clearing] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 260229 | clotrimazole 1 % Topical Powder | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 260229 | clotrimazole 1 % Topical Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 260229 | clotrimazole 1 % Topical Powder | Designated preferred name (PT) | NO | |
| RxCUI: 260229 | clotrimazole 1 % Topical Powder | Full form of descriptor (FN) | NO | |
| RxCUI: 2602290 | Differin Acne Clearing Soap Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2602291 | salicylic acid Medicated Liquid Soap [Differin Acne Clearing] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2602292 | Differin Acne Clearing 2 % Medicated Liquid Soap | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2602292 | Differin Acne Clearing 2 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2602292 | Differin Acne Clearing 2 % Medicated Liquid Soap | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2602293 | Differin Acne Clearing Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2602294 | salicylic acid Topical Spray [Differin Acne Clearing] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2602295 | Differin Acne Clearing 2 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2602295 | Differin Acne Clearing 2 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2602295 | Differin Acne Clearing 2 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2602295 | Differin Acne Clearing 2 % Topical Spray | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2602296 | ferric carboxymaltose 100 MG in 2 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2602296 | ferric carboxymaltose 100 MG in 2 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2602296 | ferric carboxymaltose 100 MG in 2 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2602297 | Injectafer (iron) 100 MG in 2 mL Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2602297 | Injectafer (iron) 100 MG in 2 mL Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2602297 | Injectafer (iron) 100 MG in 2 mL Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2602298 | tapinarof 10 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2602299 | tapinarof Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2602300 | tapinarof Topical Cream | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2602301 | tapinarof 1 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2602301 | tapinarof 1 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2602302 | Vtama | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2602303 | tapinarof 10 MG/ML [Vtama] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2602304 | Vtama Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2602305 | tapinarof Topical Cream [Vtama] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2602306 | Vtama 1 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2602306 | Vtama 1 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2602306 | Vtama 1 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 260231 | dimethyl sulfoxide 1000 MG/ML Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 260235 | iron carbonyl (as iron) 25 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 260235 | iron carbonyl (as iron) 25 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2602351 | ranibizumab-nuna | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2602352 | ranibizumab-nuna 10 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2602353 | ranibizumab-nuna 0.5 MG in 0.05 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2602353 | ranibizumab-nuna 0.5 MG in 0.05 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2602353 | ranibizumab-nuna 0.5 MG in 0.05 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2602353 | ranibizumab-nuna 0.5 MG in 0.05 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2602354 | ranibizumab-nuna 10 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2602355 | Byooviz | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2602356 | ranibizumab-nuna 10 MG/ML [Byooviz] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2602357 | Byooviz Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2602358 | ranibizumab Injection [Byooviz] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2602359 | Byooviz 0.5 MG in 0.05 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2602359 | Byooviz 0.5 MG in 0.05 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2602359 | Byooviz 0.5 MG in 0.05 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2602359 | Byooviz 0.5 MG in 0.05 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2602360 | ranibizumab-nuna 10 MG/ML Injection [Byooviz] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2602360 | ranibizumab-nuna 10 MG/ML Injection [Byooviz] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2602363 | PEMEtrexed 500 MG in 20 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2602363 | PEMEtrexed 500 MG in 20 ML Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2602363 | PEMEtrexed 500 MG in 20 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2602363 | PEMEtrexed 500 MG in 20 ML Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2602363 | PEMEtrexed 500 MG in 20 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2602364 | pemetrexed 25 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2602364 | pemetrexed 25 MG/ML Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2602365 | PEMEtrexed 1 GM in 40 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2602365 | PEMEtrexed 1 GM in 40 ML Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2602365 | PEMEtrexed 1 GM in 40 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2602365 | PEMEtrexed 1 GM in 40 ML Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2602365 | PEMEtrexed 1 GM in 40 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2602366 | PEMEtrexed 100 MG in 4 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2602366 | PEMEtrexed 100 MG in 4 ML Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2602366 | PEMEtrexed 100 MG in 4 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2602366 | PEMEtrexed 100 MG in 4 ML Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2602366 | PEMEtrexed 100 MG in 4 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 260239 | castor oil 79.3 % / Peruvian balsam 8.84 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 260239 | castor oil 79.3 % / Peruvian balsam 8.84 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 260239 | castor oil 79.3 % / Peruvian balsam 8.84 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 26024 | Glycine amidinotransferase | Designated preferred name (PT) | NO | |
| RxCUI: 26024 | Glycine amidinotransferase | Full form of descriptor (FN) | NO | |
| RxCUI: 260243 | progesterone 100 MG Oral Capsule | Full form of descriptor (FN) | YES | |
| RxCUI: 260243 | progesterone 100 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 260243 | progesterone 100 MG Oral Capsule | Designated preferred name (PT) | YES | |
| RxCUI: 260243 | progesterone 100 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 260246 | levobupivacaine 0.25 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 260247 | levobupivacaine 0.5 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 260248 | levobupivacaine 0.75 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 26025 | Glycine aminotransferase | Designated preferred name (PT) | NO | |
| RxCUI: 26025 | Glycine aminotransferase | Full form of descriptor (FN) | NO | |
| RxCUI: 260256 | rapacuronium 200 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2602563 | acetylcysteine 1200 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2602564 | acetylcysteine 1.2 GM Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2602564 | acetylcysteine 1.2 GM Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2602577 | oteseconazole | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2602578 | oteseconazole 150 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2602579 | oteseconazole Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 260258 | dextrose 250 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 260258 | dextrose 250 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2602580 | oteseconazole Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2602581 | oteseconazole Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2602582 | oteseconazole 150 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2602582 | oteseconazole 150 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2602583 | Vivjoa | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2602584 | oteseconazole 150 MG [Vivjoa] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2602585 | Vivjoa Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2602586 | Vivjoa Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2602587 | oteseconazole Oral Capsule [Vivjoa] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2602588 | Vivjoa 150 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2602588 | Vivjoa 150 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2602588 | Vivjoa 150 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 26026 | Glycine dehydrogenase | Designated preferred name (PT) | NO | |
| RxCUI: 26026 | Glycine dehydrogenase | Full form of descriptor (FN) | NO | |
| RxCUI: 260260 | carbidopa 25 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 260260 | carbidopa 25 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 260260 | carbidopa 25 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 260260 | carbidopa 25 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 260265 | insulin lispro protamine / insulin lispro 50/50 Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 260265 | insulin lispro protamine / insulin lispro 50/50 Injectable Suspension | Designated preferred name (PT) | YES | |
| RxCUI: 260265 | insulin lispro protamine / insulin lispro 50/50 Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 260265 | insulin lispro protamine / insulin lispro 50/50 Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 260265 | insulin lispro protamine / insulin lispro 50/50 Injectable Suspension | Full form of descriptor (FN) | YES | |
| RxCUI: 260269 | benzocaine 5 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 260269 | benzocaine 5 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 260269 | benzocaine 5 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2602749 | treprostinil 0.016 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2602750 | treprostinil Inhalation Powder | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2602751 | treprostinil 16 MCG Inhalation Powder | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2602751 | treprostinil 16 MCG Inhalation Powder | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2602751 | treprostinil 16 MCG Inhalation Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2602752 | treprostinil 0.016 MG [Tyvaso] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2602753 | treprostinil Inhalation Powder [Tyvaso] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2602754 | TYVASO DPI 16 MCG Inhalation Powder | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2602754 | TYVASO DPI 16 MCG Inhalation Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2602754 | TYVASO DPI 16 MCG Inhalation Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2602754 | TYVASO DPI 16 MCG Inhalation Powder | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2602755 | treprostinil 0.032 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2602756 | treprostinil 32 MCG Inhalation Powder | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2602756 | treprostinil 32 MCG Inhalation Powder | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2602756 | treprostinil 32 MCG Inhalation Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2602757 | treprostinil 0.032 MG [Tyvaso] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2602758 | TYVASO DPI 32 MCG Inhalation Powder | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2602758 | TYVASO DPI 32 MCG Inhalation Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2602758 | TYVASO DPI 32 MCG Inhalation Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2602758 | TYVASO DPI 32 MCG Inhalation Powder | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2602759 | treprostinil 0.048 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2602760 | treprostinil 48 MCG Inhalation Powder | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2602760 | treprostinil 48 MCG Inhalation Powder | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2602760 | treprostinil 48 MCG Inhalation Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2602761 | treprostinil 0.048 MG [Tyvaso] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2602762 | TYVASO DPI 48 MCG Inhalation Powder | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2602762 | TYVASO DPI 48 MCG Inhalation Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2602762 | TYVASO DPI 48 MCG Inhalation Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2602762 | TYVASO DPI 48 MCG Inhalation Powder | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2602763 | treprostinil 0.064 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2602764 | treprostinil 64 MCG Inhalation Powder | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2602764 | treprostinil 64 MCG Inhalation Powder | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2602764 | treprostinil 64 MCG Inhalation Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2602765 | treprostinil 0.064 MG [Tyvaso] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2602766 | TYVASO DPI 64 MCG Inhalation Powder | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2602766 | TYVASO DPI 64 MCG Inhalation Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2602766 | TYVASO DPI 64 MCG Inhalation Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2602766 | TYVASO DPI 64 MCG Inhalation Powder | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2602767 | treprostinil 16-32 MCG Titration Pack, 112 (16 MCG), 84 (32 MCG) | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 2602767 | treprostinil 16-32 MCG Titration Pack, 112 (16 MCG), 84 (32 MCG) | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2602767 | treprostinil 16-32 MCG Titration Pack, 112 (16 MCG), 84 (32 MCG) | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2602768 | Tyvaso DPI 16-32 MCG Titration Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 2602768 | Tyvaso DPI 16-32 MCG Titration Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2602768 | Tyvaso DPI 16-32 MCG Titration Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2602769 | treprostinil 16-32-48 MCG Titration Pack, 112 (16 MCG), 112 (32 MCG), 28 (48 MCG) | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 2602769 | treprostinil 16-32-48 MCG Titration Pack, 112 (16 MCG), 112 (32 MCG), 28 (48 MCG) | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2602769 | treprostinil 16-32-48 MCG Titration Pack, 112 (16 MCG), 112 (32 MCG), 28 (48 MCG) | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2602770 | Tyvaso DPI 16-32-48 MCG Titration Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 2602770 | Tyvaso DPI 16-32-48 MCG Titration Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2602770 | Tyvaso DPI 16-32-48 MCG Titration Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2602771 | treprostinil 32-48 MCG Institutional Pack, 16 (32 MCG), 16 (48 MCG) | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 2602771 | treprostinil 32-48 MCG Institutional Pack, 16 (32 MCG), 16 (48 MCG) | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2602771 | treprostinil 32-48 MCG Institutional Pack, 16 (32 MCG), 16 (48 MCG) | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2602772 | Tyvaso DPI 32-48 MCG Institutional Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 2602772 | Tyvaso DPI 32-48 MCG Institutional Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2602772 | Tyvaso DPI 32-48 MCG Institutional Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2602773 | treprostinil 32-48 MCG Maintenance Pack, 112 (32 MCG), 112 (48 MCG) | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 2602773 | treprostinil 32-48 MCG Maintenance Pack, 112 (32 MCG), 112 (48 MCG) | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2602773 | treprostinil 32-48 MCG Maintenance Pack, 112 (32 MCG), 112 (48 MCG) | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2602774 | Tyvaso DPI 32-48 MCG Maintenance Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 2602774 | Tyvaso DPI 32-48 MCG Maintenance Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2602774 | Tyvaso DPI 32-48 MCG Maintenance Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2602776 | Dryobalanops aromatica whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2602779 | pegfilgrastim-pbbk | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2602780 | pegfilgrastim-pbbk 10 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2602781 | pegfilgrastim-pbbk 6 MG in 0.6 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2602781 | pegfilgrastim-pbbk 6 MG in 0.6 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2602781 | pegfilgrastim-pbbk 6 MG in 0.6 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2602781 | pegfilgrastim-pbbk 6 MG in 0.6 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2602782 | pegfilgrastim-pbbk 10 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2602783 | Fylnetra | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2602784 | pegfilgrastim-pbbk 10 MG/ML [Fylnetra] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2602785 | Fylnetra Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2602786 | pegfilgrastim Prefilled Syringe [Fylnetra] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2602787 | Fylnetra 6 MG in 0.6 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2602787 | Fylnetra 6 MG in 0.6 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2602787 | Fylnetra 6 MG in 0.6 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2602787 | Fylnetra 6 MG in 0.6 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2602788 | pegfilgrastim-pbbk 10 MG/ML Prefilled Syringe [Fylnetra] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2602788 | pegfilgrastim-pbbk 10 MG/ML Prefilled Syringe [Fylnetra] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2602839 | magnesium hydroxide 600 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2602839 | magnesium hydroxide 600 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 260285 | PRED-G 0.3 % / 0.6 % Ophthalmic Ointment | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 260285 | PRED-G 0.3 % / 0.6 % Ophthalmic Ointment | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 260285 | PRED-G 0.3 % / 0.6 % Ophthalmic Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 260285 | PRED-G 0.3 % / 0.6 % Ophthalmic Ointment | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 260285 | PRED-G 0.3 % / 0.6 % Ophthalmic Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 260285 | PRED-G 0.3 % / 0.6 % Ophthalmic Ointment | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 260285 | PRED-G 0.3 % / 0.6 % Ophthalmic Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 260286 | glyburide 1.5 MG Oral Tablet [Glycron] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 260286 | glyburide 1.5 MG Oral Tablet [Glycron] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 260286 | glyburide 1.5 MG Oral Tablet [Glycron] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 260287 | glyburide 6 MG Oral Tablet [Glycron] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 260287 | glyburide 6 MG Oral Tablet [Glycron] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 260287 | glyburide 6 MG Oral Tablet [Glycron] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 260295 | erythromycin estolate 400 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 260299 | diphtheria toxoid vaccine, inactivated 0.036 MG/ML / Haemophilus capsular oligosaccharide 0.05 MG/ML Injectable Solution [Prohibit] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2603 | Clopamide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2603 | Clopamide | Designated preferred name (PT) | NO | |
| RxCUI: 2603 | Clopamide | Full form of descriptor (FN) | NO | |
| RxCUI: 2603 | Clopamide | Designated preferred name (PT) | NO | |
| RxCUI: 2603 | Clopamide | Full form of descriptor (FN) | NO | |
| RxCUI: 26030 | Glycine methyltransferase | Designated preferred name (PT) | NO | |
| RxCUI: 26030 | Glycine methyltransferase | Full form of descriptor (FN) | NO | |
| RxCUI: 260301 | Haemophilus capsular oligosaccharide 0.02 MG/ML / tetanus toxoid vaccine, inactivated 0.048 MG/ML Injectable Solution [OmniHIB] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 260302 | hydrocortisone 10 MG/ML / neomycin 3.5 MG/ML / polymyxin B 10000 UNT/ML Otic Solution [Lazersporin-C] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 260302 | hydrocortisone 10 MG/ML / neomycin 3.5 MG/ML / polymyxin B 10000 UNT/ML Otic Solution [Lazersporin-C] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 260302 | hydrocortisone 10 MG/ML / neomycin 3.5 MG/ML / polymyxin B 10000 UNT/ML Otic Solution [Lazersporin-C] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2603037 | propanediol 1-phosphate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 2603039 | zinc glycinate 20 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2603040 | zinc glycinate Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2603041 | zinc glycinate Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2603042 | zinc glycinate Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2603043 | zinc glycinate 20 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2603043 | zinc glycinate 20 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 260305 | hydrocortisone 10 MG/ML Rectal Cream [Anusert HC-1] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 260305 | hydrocortisone 10 MG/ML Rectal Cream [Anusert HC-1] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 260305 | hydrocortisone 10 MG/ML Rectal Cream [Anusert HC-1] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 260306 | hydrocortisone 10 MG/ML Rectal Cream [Anusol HC-1] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 260306 | hydrocortisone 10 MG/ML Rectal Cream [Anusol HC-1] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 260307 | Cortizone-10 Anal Itch Relief 1 % Rectal Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 260307 | Cortizone-10 Anal Itch Relief 1 % Rectal Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 260307 | Cortizone-10 Anal Itch Relief 1 % Rectal Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 260307 | Cortizone-10 Anal Itch Relief 1 % Rectal Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 260307 | Cortizone-10 Anal Itch Relief 1 % Rectal Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 260308 | hydrocortisone 10 MG/ML Rectal Cream [Nupercainal HC 1%] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 260308 | hydrocortisone 10 MG/ML Rectal Cream [Nupercainal HC 1%] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 260308 | hydrocortisone 10 MG/ML Rectal Cream [Nupercainal HC 1%] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 260311 | hydrocortisone 10 MG/ML Rectal Cream [Proctocort] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 260311 | hydrocortisone 10 MG/ML Rectal Cream [Proctocort] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 260311 | hydrocortisone 10 MG/ML Rectal Cream [Proctocort] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 260312 | Recort Plus 1 % Rectal Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 260312 | Recort Plus 1 % Rectal Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 260312 | Recort Plus 1 % Rectal Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 260312 | Recort Plus 1 % Rectal Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 260323 | Nalfon 200 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 260323 | Nalfon 200 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 260323 | Nalfon 200 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2603280 | Albatrellus confluens fruiting body extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2603281 | chromic bromide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2603282 | chromic fluoride | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2603284 | droPERidol 2.5 MG in 1ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2603284 | droPERidol 2.5 MG in 1ML Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2603284 | droPERidol 2.5 MG in 1ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2603284 | droPERidol 2.5 MG in 1ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2603284 | droPERidol 2.5 MG in 1ML Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2603287 | Physalis pubescens fruit juice | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2603288 | polyglyceryl-10 myristate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 260330 | Medrol 4 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 260330 | Medrol 4 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 260330 | Medrol 4 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 260330 | Medrol 4 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 260333 | Altace 10 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 260333 | Altace 10 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 260333 | Altace 10 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 260337 | pentoxifylline 400 MG Extended Release Oral Tablet [Pentopak] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 260337 | pentoxifylline 400 MG Extended Release Oral Tablet [Pentopak] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2603405 | Dermeleve | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2603406 | aluminum acetate 2 MG/ML [Dermeleve] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2603407 | Dermeleve Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2603408 | aluminum acetate Topical Cream [Dermeleve] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2603409 | DERMELEVE 0.2 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2603409 | DERMELEVE 0.2 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2603409 | DERMELEVE 0.2 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2603409 | DERMELEVE 0.2 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2603481 | chromic sulfate decahydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 2603482 | ascorbic acid 750 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2603482 | ascorbic acid 750 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2603482 | ascorbic acid 750 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2603482 | ascorbic acid 750 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2603483 | colloidal oatmeal 20 MG/ML [Eucerin Eczema Relief] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2603484 | Eucerin Eczema Relief Soap Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2603485 | colloidal oatmeal Medicated Liquid Soap [Eucerin Eczema Relief] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2603486 | Eucerin Eczema Relief 2 % Medicated Liquid Soap | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2603486 | Eucerin Eczema Relief 2 % Medicated Liquid Soap | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2603486 | Eucerin Eczema Relief 2 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2603486 | Eucerin Eczema Relief 2 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2603488 | racepinephrine hydrochloride 0.0001 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2603489 | lidocaine / racepinephrine / tetracaine | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| RxCUI: 2603490 | lidocaine / racepinephrine / tetracaine Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 2603491 | lidocaine / racepinephrine / tetracaine Topical Gel | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2603492 | lidocaine HCl 5 % / racepinephrine HCl 0.01 % / tetracaine HCl 1 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2603492 | lidocaine HCl 5 % / racepinephrine HCl 0.01 % / tetracaine HCl 1 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2603492 | lidocaine HCl 5 % / racepinephrine HCl 0.01 % / tetracaine HCl 1 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2603493 | heparan sulfate (porcine 5500 MW) | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 2603494 | Heparan sulfate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2603494 | Heparan sulfate | Designated preferred name (PT) | NO | |
| RxCUI: 2603494 | Heparan sulfate | Full form of descriptor (FN) | NO | |
| RxCUI: 2603494 | Heparan sulfate | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| RxCUI: 2603499 | measles virus vaccine live, attenuated Schwarz strain | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 260350 | Digitek 125 MCG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 260350 | Digitek 125 MCG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 260350 | Digitek 125 MCG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2603501 | mumps virus vaccine live, RIT-4385 strain | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2603502 | measles virus vaccine live, attenuated Schwarz strain 5024 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2603503 | mumps virus vaccine live, RIT-4385 strain 31684 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2603504 | rubella virus vaccine live (Wistar RA 27-3 strain) 3990 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2603505 | measles virus vaccine live, attenuated Schwarz strain / mumps virus vaccine live, Jeryl Lynn strain / rubella virus vaccine live (Wistar RA 27-3 strain) | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| RxCUI: 2603506 | measles virus vaccine live, attenuated Schwarz strain / mumps virus vaccine live, Jeryl Lynn strain / rubella virus vaccine live (Wistar RA 27-3 strain) Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2603507 | measles virus vaccine live, attenuated Schwarz strain / mumps virus vaccine live, Jeryl Lynn strain / rubella virus vaccine live (Wistar RA 27-3 strain) Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2603508 | measles, mumps, and rubella virus vaccine live (generic for Priorix) 0.5 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2603508 | measles, mumps, and rubella virus vaccine live (generic for Priorix) 0.5 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2603508 | measles, mumps, and rubella virus vaccine live (generic for Priorix) 0.5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2603509 | measles virus vaccine live, attenuated Schwarz strain 5024 UNT/ML / mumps virus vaccine live, RIT-4385 strain 31684 UNT/ML / rubella virus vaccine live (Wistar RA 27-3 strain) 3990 UNT/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 260351 | Digitek 250 MCG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 260351 | Digitek 250 MCG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 260351 | Digitek 250 MCG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 260351 | Digitek 250 MCG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2603510 | Priorix | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2603511 | measles virus vaccine live, attenuated Schwarz strain 5024 UNT/ML / mumps virus vaccine live, RIT-4385 strain 31684 UNT/ML / rubella virus vaccine live (Wistar RA 27-3 strain) 3990 UNT/ML [Priorix] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2603512 | Priorix Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2603513 | measles virus vaccine live, attenuated Schwarz strain / mumps virus vaccine live, Jeryl Lynn strain / rubella virus vaccine live (Wistar RA 27-3 strain) Injection [Priorix] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2603514 | PRIORIX vaccine 0.5 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2603514 | PRIORIX vaccine 0.5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2603514 | PRIORIX vaccine 0.5 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2603515 | measles virus vaccine live, attenuated Schwarz strain 5024 UNT/ML / mumps virus vaccine live, RIT-4385 strain 31684 UNT/ML / rubella virus vaccine live (Wistar RA 27-3 strain) 3990 UNT/ML Injection [Priorix] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2603516 | collagen 1000 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2603517 | ascorbic acid 10 MG / collagen 1000 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2603517 | ascorbic acid 10 MG / collagen 1000 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2603517 | ascorbic acid 10 MG / collagen 1000 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2603517 | ascorbic acid 10 MG / collagen 1000 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2603519 | magnesium chloride 71 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2603520 | calcium carbonate 118 MG / magnesium chloride 71 MG Delayed Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2603520 | calcium carbonate 118 MG / magnesium chloride 71 MG Delayed Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2603520 | calcium carbonate 118 MG / magnesium chloride 71 MG Delayed Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2603660 | dextromethorphan hydrobromide 29 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2603661 | chlorpheniramine maleate 3.5 MG / dextromethorphan HBr 29 MG / phenylephrine HCl 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2603661 | chlorpheniramine maleate 3.5 MG / dextromethorphan HBr 29 MG / phenylephrine HCl 10 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2603662 | dextromethorphan HBr 29 MG / guaiFENesin 390 MG / phenylephrine HCl 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2603662 | dextromethorphan HBr 29 MG / guaiFENesin 390 MG / phenylephrine HCl 10 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2603662 | dextromethorphan HBr 29 MG / guaiFENesin 390 MG / phenylephrine HCl 10 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2603663 | guaiFENesin 390 MG / phenylephrine HCl 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2603663 | guaiFENesin 390 MG / phenylephrine HCl 10 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2603663 | guaiFENesin 390 MG / phenylephrine HCl 10 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2603664 | methyl salicylate 10 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2603664 | methyl salicylate 10 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2603664 | methyl salicylate 10 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2603735 | Lagevrio | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2603736 | molnupiravir 200 MG [Lagevrio] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2603737 | Lagevrio Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2603738 | Lagevrio Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2603739 | molnupiravir Oral Capsule [Lagevrio] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2603740 | Lagevrio 200 MG Oral Capsule (EUA) | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2603740 | Lagevrio 200 MG Oral Capsule (EUA) | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2603740 | Lagevrio 200 MG Oral Capsule (EUA) | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2603741 | 1,4-butanedithiol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2603742 | 1-(ethyltrisulfanyl)propane | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2603743 | acetaminophen / chlorpheniramine / dextromethorphan Oral Powder Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 2603746 | acetaminophen / dextromethorphan Oral Powder Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 260375 | sulfisoxazole 100 MG/ML Oral Suspension [Gantrisin] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 260375 | sulfisoxazole 100 MG/ML Oral Suspension [Gantrisin] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 260375 | sulfisoxazole 100 MG/ML Oral Suspension [Gantrisin] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 260375 | sulfisoxazole 100 MG/ML Oral Suspension [Gantrisin] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2603751 | beryllium sulfate tetrahydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 2603752 | beryllium cation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2603757 | Fluorimax Sensitive | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2603758 | potassium nitrate 0.05 MG/MG / sodium fluoride 0.011 MG/MG [Fluorimax Sensitive] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2603759 | Fluorimax Sensitive Dental Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 260376 | terazosin HCl 10 MG Oral Capsule | Full form of descriptor (FN) | YES | |
| RxCUI: 260376 | terazosin HCl 10 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 260376 | terazosin HCl 10 MG Oral Capsule | Designated preferred name (PT) | YES | |
| RxCUI: 260376 | terazosin HCl 10 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 260376 | terazosin HCl 10 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2603760 | Fluorimax Sensitive Paste Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2603761 | Fluorimax Sensitive Oral Paste Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2603762 | Fluorimax Sensitive Toothpaste Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2603763 | potassium nitrate / sodium fluoride Toothpaste [Fluorimax Sensitive] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2603764 | FluoriMax 5000 Sensitive 5 % / 1.1 % Toothpaste | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2603764 | FluoriMax 5000 Sensitive 5 % / 1.1 % Toothpaste | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2603764 | FluoriMax 5000 Sensitive 5 % / 1.1 % Toothpaste | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2603764 | FluoriMax 5000 Sensitive 5 % / 1.1 % Toothpaste | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2603764 | FluoriMax 5000 Sensitive 5 % / 1.1 % Toothpaste | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2603766 | Fluorimax | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2603767 | sodium fluoride 0.011 MG/MG [Fluorimax] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2603768 | Fluorimax Dental Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2603769 | Fluorimax Paste Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2603770 | Fluorimax Oral Paste Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2603771 | Fluorimax Toothpaste Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2603772 | sodium fluoride Toothpaste [Fluorimax] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2603773 | Fluorimax 5000 1.1 % Toothpaste | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2603773 | Fluorimax 5000 1.1 % Toothpaste | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2603773 | Fluorimax 5000 1.1 % Toothpaste | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2603773 | Fluorimax 5000 1.1 % Toothpaste | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2603774 | Drug-Eluting Contact Lens | Dose Form (DF) | YES | |
| RxCUI: 260380 | tropicamide 5 MG/ML Ophthalmic Solution [Tropicacyl] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 260380 | tropicamide 5 MG/ML Ophthalmic Solution [Tropicacyl] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2603830 | bird-of-paradise tree whole extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2603830 | bird-of-paradise tree whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2603832 | SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 0.015 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2603833 | SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 3 MCG/0.2 ML Injectable Suspension, 6m through 4y (EUA) | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2603833 | SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 3 MCG/0.2 ML Injectable Suspension, 6m through 4y (EUA) | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2603833 | SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 3 MCG/0.2 ML Injectable Suspension, 6m through 4y (EUA) | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2603834 | ketotifen 0.019 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2603837 | Acuvue Theravision | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 260384 | dexamethasone 1 MG/ML / neomycin 3.5 MG/ML Ophthalmic Solution [AK-Neo-Dex] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 260384 | dexamethasone 1 MG/ML / neomycin 3.5 MG/ML Ophthalmic Solution [AK-Neo-Dex] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 260384 | dexamethasone 1 MG/ML / neomycin 3.5 MG/ML Ophthalmic Solution [AK-Neo-Dex] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 260384 | dexamethasone 1 MG/ML / neomycin 3.5 MG/ML Ophthalmic Solution [AK-Neo-Dex] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 260384 | dexamethasone 1 MG/ML / neomycin 3.5 MG/ML Ophthalmic Solution [AK-Neo-Dex] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 260384 | dexamethasone 1 MG/ML / neomycin 3.5 MG/ML Ophthalmic Solution [AK-Neo-Dex] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 260386 | urofollitropin 300 UNT/ML Injectable Solution [Metrodin] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 260386 | urofollitropin 300 UNT/ML Injectable Solution [Metrodin] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 260391 | prednisolone 25 MG/ML Injectable Suspension [Key-Pred] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 260391 | prednisolone 25 MG/ML Injectable Suspension [Key-Pred] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 260391 | prednisolone 25 MG/ML Injectable Suspension [Key-Pred] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 260392 | prednisolone 25 MG/ML Injectable Suspension [Predcor] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 260392 | prednisolone 25 MG/ML Injectable Suspension [Predcor] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 260392 | prednisolone 25 MG/ML Injectable Suspension [Predcor] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 260393 | prednisolone 40 MG/ML Injectable Suspension [Depo-Predate] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 260393 | prednisolone 40 MG/ML Injectable Suspension [Depo-Predate] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 260393 | prednisolone 40 MG/ML Injectable Suspension [Depo-Predate] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 260394 | prednisolone 50 MG/ML Injectable Suspension [Key-Pred] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 260394 | prednisolone 50 MG/ML Injectable Suspension [Key-Pred] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 260394 | prednisolone 50 MG/ML Injectable Suspension [Key-Pred] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 260395 | prednisolone 50 MG/ML Injectable Suspension [Medicort] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 260395 | prednisolone 50 MG/ML Injectable Suspension [Medicort] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 260395 | prednisolone 50 MG/ML Injectable Suspension [Medicort] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 260396 | prednisolone 50 MG/ML Injectable Suspension [Pred-Ject-50] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 260396 | prednisolone 50 MG/ML Injectable Suspension [Pred-Ject-50] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 260396 | prednisolone 50 MG/ML Injectable Suspension [Pred-Ject-50] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 260397 | prednisolone 50 MG/ML Injectable Suspension [Predacort 50] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 260397 | prednisolone 50 MG/ML Injectable Suspension [Predacort 50] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 260397 | prednisolone 50 MG/ML Injectable Suspension [Predacort 50] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 260398 | prednisolone 50 MG/ML Injectable Suspension [Predaject-50] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 260398 | prednisolone 50 MG/ML Injectable Suspension [Predaject-50] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 260398 | prednisolone 50 MG/ML Injectable Suspension [Predaject-50] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 260399 | prednisolone 50 MG/ML Injectable Suspension [Predalone 50] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 260399 | prednisolone 50 MG/ML Injectable Suspension [Predalone 50] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 260399 | prednisolone 50 MG/ML Injectable Suspension [Predalone 50] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2604 | Clopenthixol | Designated preferred name (PT) | NO | |
| RxCUI: 2604 | Clopenthixol | Full form of descriptor (FN) | NO | |
| RxCUI: 2604 | Clopenthixol | Designated preferred name (PT) | NO | |
| RxCUI: 2604 | Clopenthixol | Full form of descriptor (FN) | NO | |
| RxCUI: 260400 | prednisolone 50 MG/ML Injectable Suspension [Predate-50] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 260400 | prednisolone 50 MG/ML Injectable Suspension [Predate-50] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 260400 | prednisolone 50 MG/ML Injectable Suspension [Predate-50] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 260401 | prednisolone 50 MG/ML Injectable Suspension [Predcor] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 260401 | prednisolone 50 MG/ML Injectable Suspension [Predcor] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 260401 | prednisolone 50 MG/ML Injectable Suspension [Predcor] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 260402 | prednisolone 50 MG/ML Injectable Suspension [Predicort-50] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 260402 | prednisolone 50 MG/ML Injectable Suspension [Predicort-50] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 260402 | prednisolone 50 MG/ML Injectable Suspension [Predicort-50] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 260403 | prednisolone 50 MG/ML Injectable Suspension [Pri-Cortin 50] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 260403 | prednisolone 50 MG/ML Injectable Suspension [Pri-Cortin 50] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 260403 | prednisolone 50 MG/ML Injectable Suspension [Pri-Cortin 50] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2604032 | Lippia graveolens leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2604033 | withanolide D | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2604034 | ferric ferricyanide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2604035 | sodium starch glycolate type B corn | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2604036 | valnemulin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2604037 | valnemulin hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 2604038 | camphor 3 % / menthol 1.25 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2604038 | camphor 3 % / menthol 1.25 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2604038 | camphor 3 % / menthol 1.25 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2604039 | camphor 4 % / menthol 1.25 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2604039 | camphor 4 % / menthol 1.25 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2604039 | camphor 4 % / menthol 1.25 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 260404 | prednisolone 80 MG/ML Injectable Suspension [Depo-Predate] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 260404 | prednisolone 80 MG/ML Injectable Suspension [Depo-Predate] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 260404 | prednisolone 80 MG/ML Injectable Suspension [Depo-Predate] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2604040 | diclofenac sodium 0.0125 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2604041 | diclofenac / lidocaine Medicated Patch | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2604042 | lidocaine 4.5 % / diclofenac sodium 1.25 % Medicated Patch | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2604042 | lidocaine 4.5 % / diclofenac sodium 1.25 % Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2604042 | lidocaine 4.5 % / diclofenac sodium 1.25 % Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2604044 | ketotifen Drug-Eluting Contact Lens | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2604045 | ketotifen 19 MG Drug-Eluting Contact Lens | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2604045 | ketotifen 19 MG Drug-Eluting Contact Lens | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2604045 | ketotifen 19 MG Drug-Eluting Contact Lens | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2604046 | ketotifen 0.019 MG [Acuvue Theravision] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2604047 | Acuvue Theravision Ophthalmic Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2604048 | ketotifen Drug-Eluting Contact Lens [Acuvue Theravision] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2604049 | ACUVUE Theravision 19 MCG Drug-Eluting Contact Lens | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2604049 | ACUVUE Theravision 19 MCG Drug-Eluting Contact Lens | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2604049 | ACUVUE Theravision 19 MCG Drug-Eluting Contact Lens | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2604049 | ACUVUE Theravision 19 MCG Drug-Eluting Contact Lens | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 260405 | prednisolone 20 MG/ML Injectable Solution [Hydeltrasol] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 260405 | prednisolone 20 MG/ML Injectable Solution [Hydeltrasol] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 260405 | prednisolone 20 MG/ML Injectable Solution [Hydeltrasol] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 260406 | prednisolone 20 MG/ML Injectable Solution [Key-Pred SP] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 260406 | prednisolone 20 MG/ML Injectable Solution [Key-Pred SP] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 260406 | prednisolone 20 MG/ML Injectable Solution [Key-Pred SP] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 260407 | prednisolone 20 MG/ML Injectable Solution [Predicort RP] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 260407 | prednisolone 20 MG/ML Injectable Solution [Predicort RP] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 260407 | prednisolone 20 MG/ML Injectable Solution [Predicort RP] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 260408 | prednisolone acetate 20 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 260408 | prednisolone acetate 20 MG/ML Injectable Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 260409 | Pediapred 5 MG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 260409 | Pediapred 5 MG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 260409 | Pediapred 5 MG in 5 mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 260409 | Pediapred 5 MG in 5 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 260409 | Pediapred 5 MG in 5 mL Oral Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 260409 | Pediapred 5 MG in 5 mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2604172 | glycerin 1-methyl ether | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2604173 | glycerin 2-methyl ether | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 26042 | Glycoasparagine | Designated preferred name (PT) | NO | |
| RxCUI: 26042 | Glycoasparagine | Full form of descriptor (FN) | NO | |
| RxCUI: 260442 | selenium sulfide 25 MG/ML Medicated Shampoo [Exsel] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 260442 | selenium sulfide 25 MG/ML Medicated Shampoo [Exsel] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 260443 | selenium sulfide 25 MG/ML Medicated Shampoo [Glo-Sel] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 260443 | selenium sulfide 25 MG/ML Medicated Shampoo [Glo-Sel] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 260452 | vitamin B6 25 MG Oral Tablet [Vitelle Nestrex] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 260452 | vitamin B6 25 MG Oral Tablet [Vitelle Nestrex] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2604557 | dimethicone/polyglycerin-3 crosspolymer | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2604560 | 2-tert-butylcyclohexyl acetate, cis- | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 2604561 | acetaminophen 650 MG / dextromethorphan HBr 20 MG in 30 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2604561 | acetaminophen 650 MG / dextromethorphan HBr 20 MG in 30 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2604561 | acetaminophen 650 MG / dextromethorphan HBr 20 MG in 30 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2604561 | acetaminophen 650 MG / dextromethorphan HBr 20 MG in 30 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2604562 | acetaminophen 1000 MG / chlorpheniramine maleate 4 MG / dextromethorphan HBr 30 MG in 30 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2604562 | acetaminophen 1000 MG / chlorpheniramine maleate 4 MG / dextromethorphan HBr 30 MG in 30 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2604562 | acetaminophen 1000 MG / chlorpheniramine maleate 4 MG / dextromethorphan HBr 30 MG in 30 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2604562 | acetaminophen 1000 MG / chlorpheniramine maleate 4 MG / dextromethorphan HBr 30 MG in 30 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2604563 | camphor 3 % / menthol 0.1 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2604563 | camphor 3 % / menthol 0.1 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2604563 | camphor 3 % / menthol 0.1 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2604565 | ethylene dodecanedioate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2604566 | hexyl cinnamate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2604567 | lidocaine hydrochloride 4 % Medicated Liquid Soap | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2604567 | lidocaine hydrochloride 4 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2604567 | lidocaine hydrochloride 4 % Medicated Liquid Soap | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2604569 | PEG-10 beta-sitosteryl ether | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2604570 | plum juice | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2604571 | POLYQUATERNIUM-80 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2604572 | solvent yellow 29 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2604575 | Vitis vinifera stem extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2604576 | vonoprazan fumarate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2604577 | vonoprazan | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2604578 | vutrisiran | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2604579 | 1 daytime (acetaminophen 500 MG / dextromethorphan HBr 15 MG Oral Tablet) / 1 nighttime (acetaminophen 500 MG / chlorpheniramine maleate 2 MG / dextromethorphan hydrobromide 15 MG Oral Tablet) Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | NO |
| RxCUI: 2604579 | 1 daytime (acetaminophen 500 MG / dextromethorphan HBr 15 MG Oral Tablet) / 1 nighttime (acetaminophen 500 MG / chlorpheniramine maleate 2 MG / dextromethorphan hydrobromide 15 MG Oral Tablet) Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2604579 | 1 daytime (acetaminophen 500 MG / dextromethorphan HBr 15 MG Oral Tablet) / 1 nighttime (acetaminophen 500 MG / chlorpheniramine maleate 2 MG / dextromethorphan hydrobromide 15 MG Oral Tablet) Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 260458 | ferrous sulfate 250 MG Extended Release Oral Capsule [Ferrospace] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 260458 | ferrous sulfate 250 MG Extended Release Oral Capsule [Ferrospace] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 260458 | ferrous sulfate 250 MG Extended Release Oral Capsule [Ferrospace] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 260459 | ferrous sulfate 160 MG Extended Release Oral Tablet [Fe 50] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 260459 | ferrous sulfate 160 MG Extended Release Oral Tablet [Fe 50] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 260459 | ferrous sulfate 160 MG Extended Release Oral Tablet [Fe 50] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 26046 | Guanidinoacetic acid | Designated preferred name (PT) | NO | |
| RxCUI: 26046 | Guanidinoacetic acid | Full form of descriptor (FN) | NO | |
| RxCUI: 2604616 | risankizumab-rzaa 60 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2604617 | risankizumab Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2604618 | risankizumab-rzaa 600 MG in 10 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2604618 | risankizumab-rzaa 600 MG in 10 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2604618 | risankizumab-rzaa 600 MG in 10 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2604619 | risankizumab-rzaa 60 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 260462 | Head & Shoulders Intensive Treatment 1 % Medicated Shampoo | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 260462 | Head & Shoulders Intensive Treatment 1 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 260462 | Head & Shoulders Intensive Treatment 1 % Medicated Shampoo | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2604620 | risankizumab-rzaa 60 MG/ML [Skyrizi] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2604621 | risankizumab Injection [Skyrizi] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2604622 | Skyrizi 600 MG in 10 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2604622 | Skyrizi 600 MG in 10 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2604622 | Skyrizi 600 MG in 10 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2604622 | Skyrizi 600 MG in 10 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2604623 | risankizumab-rzaa 60 MG/ML Injection [Skyrizi] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2604623 | risankizumab-rzaa 60 MG/ML Injection [Skyrizi] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2604624 | risankizumab Cartridge | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2604625 | risankizumab-rzaa 360 MG in 2.4 ML Cartridge | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2604625 | risankizumab-rzaa 360 MG in 2.4 ML Cartridge | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2604625 | risankizumab-rzaa 360 MG in 2.4 ML Cartridge | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2604626 | risankizumab-rzaa 150 MG/ML Cartridge | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2604627 | risankizumab Cartridge [Skyrizi] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2604628 | Skyrizi 360 MG in 2.4 ML Cartridge | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2604628 | Skyrizi 360 MG in 2.4 ML Cartridge | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2604628 | Skyrizi 360 MG in 2.4 ML Cartridge | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2604628 | Skyrizi 360 MG in 2.4 ML Cartridge | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2604629 | risankizumab-rzaa 150 MG/ML Cartridge [Skyrizi] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2604631 | distarch phosphate, corn | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2604632 | N-acetylvaline | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2604633 | beta-phenyl-DL-phenylalanine | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 2604635 | 1 daytime (acetaminophen 33.3 MG/mL / dextromethorphan HBr 1 MG/mL Oral Solution) / 1 nighttime (acetaminophen 33.3 MG/mL / chlorpheniramine maleate 0.133 MG/mL / dextromethorphan HBr 1 MG/mL Oral Solution) Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | NO |
| RxCUI: 2604635 | 1 daytime (acetaminophen 33.3 MG/mL / dextromethorphan HBr 1 MG/mL Oral Solution) / 1 nighttime (acetaminophen 33.3 MG/mL / chlorpheniramine maleate 0.133 MG/mL / dextromethorphan HBr 1 MG/mL Oral Solution) Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2604635 | 1 daytime (acetaminophen 33.3 MG/mL / dextromethorphan HBr 1 MG/mL Oral Solution) / 1 nighttime (acetaminophen 33.3 MG/mL / chlorpheniramine maleate 0.133 MG/mL / dextromethorphan HBr 1 MG/mL Oral Solution) Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2604685 | ilodecakin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2604686 | valacyclovir hydrochloride monohydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 2604686 | valacyclovir hydrochloride monohydrate | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2604687 | gentian violet 1 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2604688 | gentian violet 0.1 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2604688 | gentian violet 0.1 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2604688 | gentian violet 0.1 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2604689 | ganaxolone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 260469 | capsicum 0.025 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 260469 | capsicum 0.025 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 260469 | capsicum 0.025 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2604690 | ganaxolone 50 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2604691 | ganaxolone Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2604692 | ganaxolone Oral Liquid Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2604693 | ganaxolone Oral Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2604694 | ganaxolone 50 MG in 1 mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2604694 | ganaxolone 50 MG in 1 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2604694 | ganaxolone 50 MG in 1 mL Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2604695 | Ztalmy | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2604696 | ganaxolone 50 MG/ML [Ztalmy] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2604697 | Ztalmy Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2604698 | Ztalmy Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2604699 | ganaxolone Oral Suspension [Ztalmy] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 260470 | capsaicin 0.2 MG/ML Topical Cream [Capzasin-P] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 260470 | capsaicin 0.2 MG/ML Topical Cream [Capzasin-P] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2604700 | Ztalmy 50 MG in 1 mL Oral Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2604700 | Ztalmy 50 MG in 1 mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2604700 | Ztalmy 50 MG in 1 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2604700 | Ztalmy 50 MG in 1 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 260471 | capsicum 0.075 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 260471 | capsicum 0.075 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 260471 | capsicum 0.075 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 260476 | vitamin E 1000 UNT (450 MG) Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 260476 | vitamin E 1000 UNT (450 MG) Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 260476 | vitamin E 1000 UNT (450 MG) Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2604767 | Tenotryl | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2604768 | enrofloxacin 100 MG/ML [Tenotryl] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2604769 | Tenotryl Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2604770 | enrofloxacin Injectable Solution [Tenotryl] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2604771 | Tenotryl 100 MG/ML Injectable Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2604771 | Tenotryl 100 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2604771 | Tenotryl 100 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2604772 | hypromellose / povidone | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| RxCUI: 2604773 | hypromellose / povidone Ophthalmic Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 2604774 | hypromellose / povidone Ophthalmic Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2604775 | hypromellose 0.3 % / povidone 0.5 % Ophthalmic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2604775 | hypromellose 0.3 % / povidone 0.5 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2604775 | hypromellose 0.3 % / povidone 0.5 % Ophthalmic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2604776 | pemetrexed tromethamine anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2604776 | pemetrexed tromethamine anhydrous | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2604778 | Lactobacillus acidophilus 17000000000 UNT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2604779 | Bifidobacterium animalis 16 Billion UNT / Lactobacillus acidophilus 17 Billion UNT Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2604779 | Bifidobacterium animalis 16 Billion UNT / Lactobacillus acidophilus 17 Billion UNT Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2604779 | Bifidobacterium animalis 16 Billion UNT / Lactobacillus acidophilus 17 Billion UNT Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2604780 | Glycylic | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2604781 | salicylic acid 0.17 MG/MG [Glycylic] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2604782 | Glycylic Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2604783 | salicylic acid Topical Gel [Glycylic] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2604784 | GlyCylic 17 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2604784 | GlyCylic 17 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2604784 | GlyCylic 17 % Topical Gel | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2604785 | vutrisiran 50 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2604786 | vutrisiran Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2604787 | vutrisiran Prefilled Syringe | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2604788 | vutrisiran 25 MG in 0.5 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2604788 | vutrisiran 25 MG in 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2604788 | vutrisiran 25 MG in 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2604789 | vutrisiran 50 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2604790 | Amvuttra | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2604791 | vutrisiran 50 MG/ML [Amvuttra] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2604792 | Amvuttra Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2604793 | vutrisiran Prefilled Syringe [Amvuttra] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2604794 | amvuttra 25 MG in 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2604794 | amvuttra 25 MG in 0.5 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2604794 | amvuttra 25 MG in 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2604794 | amvuttra 25 MG in 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2604795 | vutrisiran 50 MG/ML Prefilled Syringe [Amvuttra] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2604795 | vutrisiran 50 MG/ML Prefilled Syringe [Amvuttra] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2604796 | vonoprazan 20 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2604797 | vonoprazan Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2604798 | vonoprazan Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2604799 | vonoprazan Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2604800 | vonoprazan 20 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2604800 | vonoprazan 20 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2604800 | vonoprazan 20 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2604801 | amoxicillin 500 MG (84) / vonoprazan 20 MG (28) 14 Day DualPak Oral Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 2604801 | amoxicillin 500 MG (84) / vonoprazan 20 MG (28) 14 Day DualPak Oral Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2604801 | amoxicillin 500 MG (84) / vonoprazan 20 MG (28) 14 Day DualPak Oral Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2604802 | Voquezna 14 Day DualPak 20 MG; 500 MG | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 2604802 | Voquezna 14 Day DualPak 20 MG; 500 MG | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2604802 | Voquezna 14 Day DualPak 20 MG; 500 MG | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2604803 | amoxicillin 500 MG (56) / clarithromycin 500 MG (28) / vonoprazan 20 MG (28) 14 Day TriplePak Oral Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 2604803 | amoxicillin 500 MG (56) / clarithromycin 500 MG (28) / vonoprazan 20 MG (28) 14 Day TriplePak Oral Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2604803 | amoxicillin 500 MG (56) / clarithromycin 500 MG (28) / vonoprazan 20 MG (28) 14 Day TriplePak Oral Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2604804 | Voquezna 14 Day TriplePak 20 MG; 500 MG; 500 MG | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 2604804 | Voquezna 14 Day TriplePak 20 MG; 500 MG; 500 MG | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2604804 | Voquezna 14 Day TriplePak 20 MG; 500 MG; 500 MG | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 260485 | coal tar 50 MG/ML Medicated Shampoo [Reme-T] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 260485 | coal tar 50 MG/ML Medicated Shampoo [Reme-T] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 260485 | coal tar 50 MG/ML Medicated Shampoo [Reme-T] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2604877 | lidocaine hydrochloride 0.02 MG/MG [Regenecare] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2604878 | lidocaine Topical Gel [Regenecare] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2604879 | REGENECARE HA 2 % Topical Gel | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2604879 | REGENECARE HA 2 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2604879 | REGENECARE HA 2 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2604880 | Chlorhexidine diacetate 200 microgram/mL cutaneous solution | Designated preferred name (PT) | NO | |
| RxCUI: 2604880 | Chlorhexidine diacetate 200 microgram/mL cutaneous solution | Full form of descriptor (FN) | NO | |
| RxCUI: 2604882 | Chlorhexidine diacetate 500 microgram/mL cutaneous solution | Designated preferred name (PT) | NO | |
| RxCUI: 2604882 | Chlorhexidine diacetate 500 microgram/mL cutaneous solution | Full form of descriptor (FN) | NO | |
| RxCUI: 260491 | ichthammol 0.2 MG/MG Topical Ointment [Drawing Salve] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 260491 | ichthammol 0.2 MG/MG Topical Ointment [Drawing Salve] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 260491 | ichthammol 0.2 MG/MG Topical Ointment [Drawing Salve] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 260492 | RID 3 % / 0.3 % Medicated Shampoo | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 260492 | RID 3 % / 0.3 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 260492 | RID 3 % / 0.3 % Medicated Shampoo | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2604934 | chlorhexidine gluconate 0.2 % / ketoconazole 0.2 % Medicated Pad | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2604934 | chlorhexidine gluconate 0.2 % / ketoconazole 0.2 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2604934 | chlorhexidine gluconate 0.2 % / ketoconazole 0.2 % Medicated Pad | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 260494 | chromous chloride 0.001 MG/ML / copper sulfate 0.1 MG/ML / manganese sulfate 0.02 MG/ML / selenious acid 0.015 MG/ML / zinc sulfate 1 MG/ML Injectable Solution [P.T.E.-5] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 260494 | chromous chloride 0.001 MG/ML / copper sulfate 0.1 MG/ML / manganese sulfate 0.02 MG/ML / selenious acid 0.015 MG/ML / zinc sulfate 1 MG/ML Injectable Solution [P.T.E.-5] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 260495 | chromous chloride 0.004 MG/ML / copper sulfate 0.4 MG/ML / manganese sulfate 0.1 MG/ML / selenious acid 0.02 MG/ML / zinc sulfate 1 MG/ML Injectable Solution [M.T.E.-5] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 260495 | chromous chloride 0.004 MG/ML / copper sulfate 0.4 MG/ML / manganese sulfate 0.1 MG/ML / selenious acid 0.02 MG/ML / zinc sulfate 1 MG/ML Injectable Solution [M.T.E.-5] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 260495 | chromous chloride 0.004 MG/ML / copper sulfate 0.4 MG/ML / manganese sulfate 0.1 MG/ML / selenious acid 0.02 MG/ML / zinc sulfate 1 MG/ML Injectable Solution [M.T.E.-5] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 260496 | chromous chloride 0.004 MG/ML / copper sulfate 0.4 MG/ML / manganese sulfate 0.1 MG/ML / selenious acid 0.02 MG/ML / zinc sulfate 1 MG/ML Injectable Solution [MulTE-PAK-5] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 260496 | chromous chloride 0.004 MG/ML / copper sulfate 0.4 MG/ML / manganese sulfate 0.1 MG/ML / selenious acid 0.02 MG/ML / zinc sulfate 1 MG/ML Injectable Solution [MulTE-PAK-5] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 260496 | chromous chloride 0.004 MG/ML / copper sulfate 0.4 MG/ML / manganese sulfate 0.1 MG/ML / selenious acid 0.02 MG/ML / zinc sulfate 1 MG/ML Injectable Solution [MulTE-PAK-5] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 260499 | chromous chloride 0.004 MG/ML / copper sulfate 0.4 MG/ML / manganese chloride 0.1 MG/ML / selenious acid 0.02 MG/ML / sodium iodide 0.025 MG/ML / zinc sulfate 1 MG/ML Injectable Solution [M.T.E.-6] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 260499 | chromous chloride 0.004 MG/ML / copper sulfate 0.4 MG/ML / manganese chloride 0.1 MG/ML / selenious acid 0.02 MG/ML / sodium iodide 0.025 MG/ML / zinc sulfate 1 MG/ML Injectable Solution [M.T.E.-6] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 26050 | Glycogenin | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 26050 | Glycogenin | Designated preferred name (PT) | NO | |
| RxCUI: 26050 | Glycogenin | Full form of descriptor (FN) | NO | |
| RxCUI: 260500 | chromous chloride 0.004 MG/ML / copper sulfate 0.4 MG/ML / manganese chloride 0.1 MG/ML / molybdenum 0.025 MG/ML / selenious acid 0.02 MG/ML / sodium iodide 0.025 MG/ML / zinc sulfate 1 MG/ML Injectable Solution [M.T.E.-7] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 260500 | chromous chloride 0.004 MG/ML / copper sulfate 0.4 MG/ML / manganese chloride 0.1 MG/ML / molybdenum 0.025 MG/ML / selenious acid 0.02 MG/ML / sodium iodide 0.025 MG/ML / zinc sulfate 1 MG/ML Injectable Solution [M.T.E.-7] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 260502 | Desitin Maximum Strength Original 40 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 260502 | Desitin Maximum Strength Original 40 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 260502 | Desitin Maximum Strength Original 40 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 260502 | Desitin Maximum Strength Original 40 % Topical Ointment | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 260502 | Desitin Maximum Strength Original 40 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2605033 | Benadryl 50 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2605033 | Benadryl 50 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2605033 | Benadryl 50 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2605033 | Benadryl 50 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2605039 | influenza B virus B/Austria/1359417/2021 antigen | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2605044 | influenza B virus B/Austria/1359417/2021 antigen 0.03 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2605045 | influenza virus vaccine 2022-2023 (quadrivalent - Austria/Darwin-9/Phuket/Victoria) 0.5 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2605045 | influenza virus vaccine 2022-2023 (quadrivalent - Austria/Darwin-9/Phuket/Victoria) 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2605045 | influenza virus vaccine 2022-2023 (quadrivalent - Austria/Darwin-9/Phuket/Victoria) 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2605046 | influenza virus vaccine 2022-2023 (quadrivalent - Darwin/Victoria/Austria/Phuket) Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2605046 | influenza virus vaccine 2022-2023 (quadrivalent - Darwin/Victoria/Austria/Phuket) Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2605046 | influenza virus vaccine 2022-2023 (quadrivalent - Darwin/Victoria/Austria/Phuket) Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2605047 | Flulaval Quadrivalent 2022-2023 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2605048 | influenza A virus A/Darwin/9/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Austria/1359417/2021 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML [Flulaval Quadrivalent 2022-2023] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2605049 | Flulaval Quadrivalent 2022-2023 Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2605050 | influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Flulaval Quadrivalent 2022-2023] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2605051 | FLULAVAL QUADRIVALENT 2022-2023 vaccine 0.5 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2605051 | FLULAVAL QUADRIVALENT 2022-2023 vaccine 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2605051 | FLULAVAL QUADRIVALENT 2022-2023 vaccine 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2605052 | FLULAVAL QUADRIVALENT 2022-2023 vaccine Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2605052 | FLULAVAL QUADRIVALENT 2022-2023 vaccine Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2605052 | FLULAVAL QUADRIVALENT 2022-2023 vaccine Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2605053 | carmustine 300 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2605054 | carmustine 300 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2605054 | carmustine 300 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2605054 | carmustine 300 MG Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2605055 | carmustine 50 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2605056 | carmustine 50 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2605056 | carmustine 50 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2605056 | carmustine 50 MG Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 260506 | zinc oxide 0.4 MG/MG Topical Ointment [Little Bottoms Diaper Rash] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 260506 | zinc oxide 0.4 MG/MG Topical Ointment [Little Bottoms Diaper Rash] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 260506 | zinc oxide 0.4 MG/MG Topical Ointment [Little Bottoms Diaper Rash] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2605083 | influenza A virus A/Darwin/6/2021 (H3N2) antigen | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2605085 | Limonia acidissima whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2605086 | methyl 3-hydroxyhexanoate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2605089 | influenza A virus A/Darwin/6/2021 (H3N2) antigen 0.03 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 260509 | ascorbic acid 150 MG / ferrous sulfate 60 MG Extended Release Oral Tablet [Vitelle Irospan] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 260509 | ascorbic acid 150 MG / ferrous sulfate 60 MG Extended Release Oral Tablet [Vitelle Irospan] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 260509 | ascorbic acid 150 MG / ferrous sulfate 60 MG Extended Release Oral Tablet [Vitelle Irospan] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 260509 | ascorbic acid 150 MG / ferrous sulfate 60 MG Extended Release Oral Tablet [Vitelle Irospan] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 260509 | ascorbic acid 150 MG / ferrous sulfate 60 MG Extended Release Oral Tablet [Vitelle Irospan] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2605090 | influenza virus vaccine 2022-2023 (quadrivalent - Austria/Darwin-6/Phuket/Victoria) 0.5 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2605090 | influenza virus vaccine 2022-2023 (quadrivalent - Austria/Darwin-6/Phuket/Victoria) 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2605090 | influenza virus vaccine 2022-2023 (quadrivalent - Austria/Darwin-6/Phuket/Victoria) 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2605091 | influenza virus vaccine 2022-2023 (quadrivalent - Austria/Darwin/Phuket/Victoria) Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2605091 | influenza virus vaccine 2022-2023 (quadrivalent - Austria/Darwin/Phuket/Victoria) Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2605091 | influenza virus vaccine 2022-2023 (quadrivalent - Austria/Darwin/Phuket/Victoria) Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2605092 | Fluarix Quadrivalent 2022-2023 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2605093 | influenza A virus A/Darwin/6/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Austria/1359417/2021 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML [Fluarix Quadrivalent 2022-2023] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2605094 | Fluarix Quadrivalent 2022-2023 Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2605095 | influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Fluarix Quadrivalent 2022-2023] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2605096 | FLUARIX QUADRIVALENT 2022-2023 vaccine 0.5 mL Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2605096 | FLUARIX QUADRIVALENT 2022-2023 vaccine 0.5 mL Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2605096 | FLUARIX QUADRIVALENT 2022-2023 vaccine 0.5 mL Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2605097 | influenza A virus A/Darwin/6/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Austria/1359417/2021 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Fluarix Quadrivalent 2022-2023] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2605098 | influenza A virus A/Darwin/9/2021 (H3N2) antigen 0.0857 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2605099 | influenza B virus B/Michigan/01/2021 antigen 0.0857 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 26051 | Glycol monosalicylate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 26051 | Glycol monosalicylate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 26051 | Glycol monosalicylate | Designated preferred name (PT) | YES | |
| RxCUI: 26051 | Glycol monosalicylate | Full form of descriptor (FN) | YES | |
| RxCUI: 26051 | Glycol monosalicylate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 260510 | ascorbic acid 150 MG / ferrous sulfate 60 MG Extended Release Oral Capsule [Vitelle Irospan] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 260510 | ascorbic acid 150 MG / ferrous sulfate 60 MG Extended Release Oral Capsule [Vitelle Irospan] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 260510 | ascorbic acid 150 MG / ferrous sulfate 60 MG Extended Release Oral Capsule [Vitelle Irospan] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 260510 | ascorbic acid 150 MG / ferrous sulfate 60 MG Extended Release Oral Capsule [Vitelle Irospan] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 260510 | ascorbic acid 150 MG / ferrous sulfate 60 MG Extended Release Oral Capsule [Vitelle Irospan] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2605100 | influenza virus vaccine 2022-2023 high-dose (quadrivalent - Darwin/Michigan/Phuket/Victoria) 0.7 mL Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2605100 | influenza virus vaccine 2022-2023 high-dose (quadrivalent - Darwin/Michigan/Phuket/Victoria) 0.7 mL Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2605100 | influenza virus vaccine 2022-2023 high-dose (quadrivalent - Darwin/Michigan/Phuket/Victoria) 0.7 mL Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2605101 | influenza A virus A/Darwin/9/2021 (H3N2) antigen 0.0857 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.0857 MG/ML / influenza B virus B/Michigan/01/2021 antigen 0.0857 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.0857 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2605102 | Fluzone Quadrivalent 2022-2023 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2605103 | influenza A virus A/Darwin/9/2021 (H3N2) antigen 0.0857 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.0857 MG/ML / influenza B virus B/Michigan/01/2021 antigen 0.0857 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.0857 MG/ML [Fluzone Quadrivalent 2022-2023] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2605104 | Fluzone Quadrivalent 2022-2023 Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2605105 | influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Fluzone Quadrivalent 2022-2023] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2605106 | Fluzone Quadrivalent 2022-2023 high dose vaccine 0.7 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2605106 | Fluzone Quadrivalent 2022-2023 high dose vaccine 0.7 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2605106 | Fluzone Quadrivalent 2022-2023 high dose vaccine 0.7 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2605107 | influenza A virus A/Darwin/9/2021 (H3N2) antigen 0.0857 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.0857 MG/ML / influenza B virus B/Michigan/01/2021 antigen 0.0857 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.0857 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2022-2023] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 26053 | Glycolaldehyde dehydrogenase | Designated preferred name (PT) | NO | |
| RxCUI: 26053 | Glycolaldehyde dehydrogenase | Full form of descriptor (FN) | NO | |
| RxCUI: 2605341 | PEMEtrexed 840 MG in 34 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2605341 | PEMEtrexed 840 MG in 34 ML Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2605341 | PEMEtrexed 840 MG in 34 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2605341 | PEMEtrexed 840 MG in 34 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2605341 | PEMEtrexed 840 MG in 34 ML Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2605536 | Fluad Quadrivalent 2022-2023 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2605537 | influenza A virus A/Darwin/6/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Austria/1359417/2021 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML [Fluad Quadrivalent 2022-2023] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2605538 | Fluad Quadrivalent 2022-2023 Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2605539 | influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Fluad Quadrivalent 2022-2023] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2605540 | FLUAD Quadrivalent 2022-2023 vaccine 0.5 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2605540 | FLUAD Quadrivalent 2022-2023 vaccine 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2605540 | FLUAD Quadrivalent 2022-2023 vaccine 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2605541 | FLUAD Quadrivalent 2022-2023 vaccine Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2605541 | FLUAD Quadrivalent 2022-2023 vaccine Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2605541 | FLUAD Quadrivalent 2022-2023 vaccine Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2605542 | influenza A virus A/Darwin/9/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Michigan/01/2021 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML [Fluzone Quadrivalent 2022-2023] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2605543 | Fluzone Quadrivalent 2022-2023 Northern Hemisphere vaccine 0.5 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2605543 | Fluzone Quadrivalent 2022-2023 Northern Hemisphere vaccine 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2605543 | Fluzone Quadrivalent 2022-2023 Northern Hemisphere vaccine 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2605544 | Fluzone Quadrivalent 2022-2023 Northern Hemisphere vaccine Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2605544 | Fluzone Quadrivalent 2022-2023 Northern Hemisphere vaccine Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2605544 | Fluzone Quadrivalent 2022-2023 Northern Hemisphere vaccine Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2605546 | influenza virus vaccine 2022-2023 (quadrivalent - Darwin/Victoria/Michigan/Phuket) 0.5 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2605546 | influenza virus vaccine 2022-2023 (quadrivalent - Darwin/Victoria/Michigan/Phuket) 0.5 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2605546 | influenza virus vaccine 2022-2023 (quadrivalent - Darwin/Victoria/Michigan/Phuket) 0.5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2605547 | influenza virus vaccine 2022-2023 (quadrivalent - Darwin/Victoria/Michigan/Phuket) Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2605547 | influenza virus vaccine 2022-2023 (quadrivalent - Darwin/Victoria/Michigan/Phuket) Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2605547 | influenza virus vaccine 2022-2023 (quadrivalent - Darwin/Victoria/Michigan/Phuket) Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2605548 | influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injection [Fluzone Quadrivalent 2022-2023] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2605549 | Fluzone Quadrivalent 2022-2023 Northern Hemisphere vaccine 0.5 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2605549 | Fluzone Quadrivalent 2022-2023 Northern Hemisphere vaccine 0.5 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2605549 | Fluzone Quadrivalent 2022-2023 Northern Hemisphere vaccine 0.5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2605550 | Fluzone Quadrivalent 2022-2023 Northern Hemisphere vaccine Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2605550 | Fluzone Quadrivalent 2022-2023 Northern Hemisphere vaccine Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2605550 | Fluzone Quadrivalent 2022-2023 Northern Hemisphere vaccine Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2605551 | influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injectable Suspension [Fluzone Quadrivalent 2022-2023] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2605552 | Fluzone Quadrivalent 2022-2023 Northern Hemisphere vaccine Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2605552 | Fluzone Quadrivalent 2022-2023 Northern Hemisphere vaccine Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2605552 | Fluzone Quadrivalent 2022-2023 Northern Hemisphere vaccine Injectable Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2605553 | Afluria Quadrivalent 2022-2023 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2605554 | influenza A virus A/Darwin/6/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Austria/1359417/2021 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML [Afluria Quadrivalent 2022-2023] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2605555 | Afluria Quadrivalent 2022-2023 Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2605556 | influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Afluria Quadrivalent 2022-2023] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2605557 | Afluria Quadrivalent 2022-2023 vaccine 0.5 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2605557 | Afluria Quadrivalent 2022-2023 vaccine 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2605557 | Afluria Quadrivalent 2022-2023 vaccine 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2605558 | Afluria Quadrivalent 2022-2023 vaccine Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2605558 | Afluria Quadrivalent 2022-2023 vaccine Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2605558 | Afluria Quadrivalent 2022-2023 vaccine Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2605559 | influenza virus vaccine 2022-2023 (quadrivalent - Darwin/Victoria/Austria/Phuket) Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2605559 | influenza virus vaccine 2022-2023 (quadrivalent - Darwin/Victoria/Austria/Phuket) Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2605559 | influenza virus vaccine 2022-2023 (quadrivalent - Darwin/Victoria/Austria/Phuket) Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2605560 | influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injectable Suspension [Afluria Quadrivalent 2022-2023] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2605561 | Afluria Quadrivalent 2022-2023 vaccine Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2605561 | Afluria Quadrivalent 2022-2023 vaccine Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2605561 | Afluria Quadrivalent 2022-2023 vaccine Injectable Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2605562 | influenza A virus A/Darwin/6/2021 (H3N2) antigen 0.09 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2605563 | influenza B virus B/Austria/1359417/2021 antigen 0.09 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2605564 | influenza virus vaccine 2022-2023 (quadrivalent - Darwin/Wisconsin/Austria/Phuket) 0.5 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2605564 | influenza virus vaccine 2022-2023 (quadrivalent - Darwin/Wisconsin/Austria/Phuket) 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2605564 | influenza virus vaccine 2022-2023 (quadrivalent - Darwin/Wisconsin/Austria/Phuket) 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2605565 | influenza virus vaccine 2022-2023 (quadrivalent - Darwin/Wisconsin/Austria/Phuket) Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2605565 | influenza virus vaccine 2022-2023 (quadrivalent - Darwin/Wisconsin/Austria/Phuket) Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2605565 | influenza virus vaccine 2022-2023 (quadrivalent - Darwin/Wisconsin/Austria/Phuket) Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2605566 | Flublok Quadrivalent 2022-2023 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2605567 | influenza A virus A/Darwin/6/2021 (H3N2) antigen 0.09 MG/ML / influenza A virus A/Wisconsin/588/2019 (H1N1) antigen 0.09 MG/ML / influenza B virus B/Austria/1359417/2021 antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML [Flublok Quadrivalent 2022-2023] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2605568 | Flublok Quadrivalent 2022-2023 Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2605569 | influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Flublok Quadrivalent 2022-2023] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2605570 | FLUBLOK Quadrivalent 2022-2023 vaccine 0.5 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2605570 | FLUBLOK Quadrivalent 2022-2023 vaccine 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2605570 | FLUBLOK Quadrivalent 2022-2023 vaccine 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2605571 | FLUBLOK Quadrivalent 2022-2023 vaccine Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2605571 | FLUBLOK Quadrivalent 2022-2023 vaccine Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2605571 | FLUBLOK Quadrivalent 2022-2023 vaccine Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2605574 | vutrisiran sodium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 2605590 | maltobionic acid | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2605591 | maltobionate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2605592 | sulfur 8 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2605592 | sulfur 8 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2605592 | sulfur 8 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2605718 | 5-hydroxytryptophan Extended Release Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2605720 | 5-HTP 100 MG Extended Release Oral Tablets | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2605720 | 5-HTP 100 MG Extended Release Oral Tablets | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2605721 | menthol / panthenol / salicylic acid Topical Spray | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2605722 | menthol 0.3 % / panthenol 0.2 % / salicylic acid 0.25 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2605722 | menthol 0.3 % / panthenol 0.2 % / salicylic acid 0.25 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2605722 | menthol 0.3 % / panthenol 0.2 % / salicylic acid 0.25 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2605723 | influenza A virus A/Darwin/11/2021 (H3N2) antigen | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2605724 | influenza A virus A/Delaware/55/2019 (H1N1) antigen | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2605725 | influenza B virus B/Singapore/WUH4618/2021 antigen | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2605726 | influenza A virus A/Darwin/11/2021 (H3N2) antigen 0.03 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2605727 | influenza A virus A/Delaware/55/2019 (H1N1) antigen 0.03 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2605728 | influenza B virus B/Singapore/WUH4618/2021 antigen 0.03 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2605729 | influenza virus vaccine 2022-2023 (quadrivalent - Darwin/Delaware/Singapore INFTT-16-0610/Singapore WUH4618) 0.5 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2605729 | influenza virus vaccine 2022-2023 (quadrivalent - Darwin/Delaware/Singapore INFTT-16-0610/Singapore WUH4618) 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2605729 | influenza virus vaccine 2022-2023 (quadrivalent - Darwin/Delaware/Singapore INFTT-16-0610/Singapore WUH4618) 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2605730 | influenza A virus A/Darwin/11/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Delaware/55/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen 0.03 MG/ML / influenza B virus B/Singapore/WUH4618/2021 antigen 0.03 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2605731 | Flucelvax Quadrivalent 2022-2023 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2605732 | influenza A virus A/Darwin/11/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Delaware/55/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen 0.03 MG/ML / influenza B virus B/Singapore/WUH4618/2021 antigen 0.03 MG/ML [Flucelvax Quadrivalent 2022-2023] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2605733 | Flucelvax Quadrivalent 2022-2023 Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2605734 | influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Flucelvax Quadrivalent 2022-2023] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2605735 | FLUCELVAX Quadrivalent 2022-2023 vaccine 0.5 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2605735 | FLUCELVAX Quadrivalent 2022-2023 vaccine 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2605735 | FLUCELVAX Quadrivalent 2022-2023 vaccine 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2605736 | influenza A virus A/Darwin/11/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Delaware/55/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen 0.03 MG/ML / influenza B virus B/Singapore/WUH4618/2021 antigen 0.03 MG/ML Prefilled Syringe [Flucelvax Quadrivalent 2022-2023] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2605737 | influenza virus vaccine 2022-2023 (quadrivalent - Darwin/Delaware/Singapore INFTT-16-0610/Singapore WUH4618) Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2605737 | influenza virus vaccine 2022-2023 (quadrivalent - Darwin/Delaware/Singapore INFTT-16-0610/Singapore WUH4618) Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2605737 | influenza virus vaccine 2022-2023 (quadrivalent - Darwin/Delaware/Singapore INFTT-16-0610/Singapore WUH4618) Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2605738 | influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injectable Suspension [Flucelvax Quadrivalent 2022-2023] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2605739 | FLUCELVAX Quadrivalent 2022-2023 vaccine Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2605739 | FLUCELVAX Quadrivalent 2022-2023 vaccine Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2605739 | FLUCELVAX Quadrivalent 2022-2023 vaccine Injectable Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2605793 | povidone 2.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2605794 | povidone 0.25 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2605794 | povidone 0.25 % Ophthalmic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2605794 | povidone 0.25 % Ophthalmic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2605795 | methylphenidate hydrochloride 63 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2605796 | methylphenidate HCl 63 MG 24HR Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2605796 | methylphenidate HCl 63 MG 24HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2605796 | methylphenidate HCl 63 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2605797 | methylphenidate hydrochloride 63 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2605798 | methylphenidate hydrochloride 45 MG 24HR Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2605798 | methylphenidate hydrochloride 45 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2605798 | methylphenidate hydrochloride 45 MG 24HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2605799 | methylphenidate hydrochloride 45 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 26058 | Glycolate oxidase | Designated preferred name (PT) | NO | |
| RxCUI: 26058 | Glycolate oxidase | Full form of descriptor (FN) | NO | |
| RxCUI: 26058 | Glycolate oxidase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 26058 | Glycolate oxidase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 26058 | Glycolate oxidase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2605800 | menthol 2 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2605800 | menthol 2 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2605800 | menthol 2 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2605801 | anisyl acetate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2605802 | oteseconazole 150 MG 18-Count Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 2605802 | oteseconazole 150 MG 18-Count Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2605802 | oteseconazole 150 MG 18-Count Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2605803 | vivjoa 18-Count Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 2605803 | vivjoa 18-Count Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2605803 | vivjoa 18-Count Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2605942 | methylphenidate hydrochloride 45 MG [Relexxii] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2605943 | RELEXXII 45 MG 24HR Extended Release Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2605943 | RELEXXII 45 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2605943 | RELEXXII 45 MG 24HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2605944 | methylphenidate hydrochloride 45 MG Extended Release Oral Tablet [Relexxii] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2605944 | methylphenidate hydrochloride 45 MG Extended Release Oral Tablet [Relexxii] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2605945 | methylphenidate hydrochloride 63 MG [Relexxii] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2605946 | RELEXXII 63 MG 24HR Extended Release Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2605946 | RELEXXII 63 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2605946 | RELEXXII 63 MG 24HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2605947 | methylphenidate hydrochloride 63 MG Extended Release Oral Tablet [Relexxii] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2605947 | methylphenidate hydrochloride 63 MG Extended Release Oral Tablet [Relexxii] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2605948 | venlafaxine besylate monohydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2605949 | venlafaxine 112.5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2605950 | venlafaxine 112.5 MG 24HR Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2605950 | venlafaxine 112.5 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2605950 | venlafaxine 112.5 MG 24HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2605951 | venlafaxine 112.5 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2606 | Cloprostenol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2606 | Cloprostenol | Designated preferred name (PT) | NO | |
| RxCUI: 2606 | Cloprostenol | Full form of descriptor (FN) | NO | |
| RxCUI: 26060 | Peptide N-glycosidase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 26060 | Peptide N-glycosidase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 26060 | Peptide N-glycosidase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 26060 | Peptide N-glycosidase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 26060 | Peptide N-glycosidase | Designated preferred name (PT) | NO | |
| RxCUI: 26060 | Peptide N-glycosidase | Full form of descriptor (FN) | NO | |
| RxCUI: 2606064 | camphor 1.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2606065 | camphor 0.15 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2606065 | camphor 0.15 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2606065 | camphor 0.15 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2606066 | Coccinia grandis whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2606067 | surinamine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2606068 | camphor 3 % / menthol 3 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2606068 | camphor 3 % / menthol 3 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2606068 | camphor 3 % / menthol 3 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2606069 | 1 daytime (acetaminophen 325 MG / dextromethorphan hydrobromide 10 MG / phenylephrine hydrochloride 5 MG Oral Capsule) / 1 nighttime (acetaminophen 325 MG / chlorpheniramine maleate 2 MG / phenylephrine hydrochloride 5 MG Oral Capsule) Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | NO |
| RxCUI: 2606069 | 1 daytime (acetaminophen 325 MG / dextromethorphan hydrobromide 10 MG / phenylephrine hydrochloride 5 MG Oral Capsule) / 1 nighttime (acetaminophen 325 MG / chlorpheniramine maleate 2 MG / phenylephrine hydrochloride 5 MG Oral Capsule) Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2606069 | 1 daytime (acetaminophen 325 MG / dextromethorphan hydrobromide 10 MG / phenylephrine hydrochloride 5 MG Oral Capsule) / 1 nighttime (acetaminophen 325 MG / chlorpheniramine maleate 2 MG / phenylephrine hydrochloride 5 MG Oral Capsule) Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2606073 | SARS-CoV-2 (COVID-19) vaccine, protein NVX-CoV2373 | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2606074 | SARS-COV-2 (COVID-19) vaccine, subunit, recombinant spike protein | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2606075 | SARS-CoV-2 (COVID-19) vaccine, protein NVX-CoV2373 0.01 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2606076 | SARS-COV-2 (COVID-19) vaccine, subunit, recombinant spike protein Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2606077 | SARS-COV-2 (COVID-19) vaccine, subunit, recombinant spike protein Injectable Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2606078 | SARS-CoV-2 (COVID-19) vaccine, protein NVX-CoV2373 5 MCG/0.5 ML Injectable Suspension (EUA) | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2606078 | SARS-CoV-2 (COVID-19) vaccine, protein NVX-CoV2373 5 MCG/0.5 ML Injectable Suspension (EUA) | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2606078 | SARS-CoV-2 (COVID-19) vaccine, protein NVX-CoV2373 5 MCG/0.5 ML Injectable Suspension (EUA) | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2606078 | SARS-CoV-2 (COVID-19) vaccine, protein NVX-CoV2373 5 MCG/0.5 ML Injectable Suspension (EUA) | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2606079 | aspirin 325 MG Effervescent Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2606079 | aspirin 325 MG Effervescent Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2606079 | aspirin 325 MG Effervescent Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2606080 | menthol 9.3 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2606081 | menthol 9.3 MG Oral Lozenge | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2606081 | menthol 9.3 MG Oral Lozenge | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 26061 | Glycopeptide alpha-N-acetylgalactosaminidase | Designated preferred name (PT) | NO | |
| RxCUI: 26061 | Glycopeptide alpha-N-acetylgalactosaminidase | Full form of descriptor (FN) | NO | |
| RxCUI: 2606311 | Bursera graveolens fruit oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2606312 | zinc pyrithione 10 MG/ML [Dandrene] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2606313 | Dandrene 1 % Medicated Shampoo | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2606313 | Dandrene 1 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2606313 | Dandrene 1 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2606313 | Dandrene 1 % Medicated Shampoo | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2606479 | cobalt oxide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2606481 | cobaltous carbonate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2606482 | Cryptomeria japonica whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2606483 | Canavalia gladiata whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2606484 | Iomeprol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2606484 | Iomeprol | Designated preferred name (PT) | YES | |
| RxCUI: 2606484 | Iomeprol | Full form of descriptor (FN) | YES | |
| RxCUI: 2606484 | Iomeprol | Designated preferred name (PT) | YES | |
| RxCUI: 2606484 | Iomeprol | Full form of descriptor (FN) | YES | |
| RxCUI: 2606489 | pirfenidone 534 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2606490 | pirfenidone 534 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2606490 | pirfenidone 534 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2606491 | pirfenidone 267 MG Capsule 14 Day Titration Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 2606491 | pirfenidone 267 MG Capsule 14 Day Titration Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2606491 | pirfenidone 267 MG Capsule 14 Day Titration Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2606493 | keratin, type I cytoskeletal 40 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2606512 | trimethylsilyl trihydrogen silicate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2606514 | leuprolide acetate 22.5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2606515 | leuprolide Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2606516 | leuprolide acetate 22.5 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2606516 | leuprolide acetate 22.5 MG Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2606516 | leuprolide acetate 22.5 MG Injection | Designated preferred name (PT) | YES | |
| RxCUI: 2606516 | leuprolide acetate 22.5 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2606516 | leuprolide acetate 22.5 MG Injection | Full form of descriptor (FN) | YES | |
| RxCUI: 2606543 | Ag - Silver | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2606543 | Ag - Silver | Full form of descriptor (FN) | YES | |
| RxCUI: 2606543 | Ag - Silver | Full form of descriptor (FN) | YES | |
| RxCUI: 2606543 | Ag - Silver | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2606543 | Ag - Silver | Designated preferred name (PT) | YES | |
| RxCUI: 2606543 | Ag - Silver | Full form of descriptor (FN) | YES | |
| RxCUI: 2606543 | Ag - Silver | Designated preferred name (PT) | YES | |
| RxCUI: 2606543 | Ag - Silver | Full form of descriptor (FN) | YES | |
| RxCUI: 2606543 | Ag - Silver | Designated preferred name (PT) | YES | |
| RxCUI: 2606543 | Ag - Silver | Designated preferred name (PT) | YES | |
| RxCUI: 2606544 | Julie | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2606545 | levonorgestrel 1.5 MG [Julie] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2606546 | Julie Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2606547 | Julie Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2606548 | levonorgestrel Oral Tablet [Julie] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2606549 | Julie 1.5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2606549 | Julie 1.5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2606549 | Julie 1.5 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2606550 | oxymetazoline hydrochloride 0.025 % Nasal Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2606550 | oxymetazoline hydrochloride 0.025 % Nasal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2606550 | oxymetazoline hydrochloride 0.025 % Nasal Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2606551 | Afrin 0.025 % Nasal Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2606551 | Afrin 0.025 % Nasal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2606551 | Afrin 0.025 % Nasal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2606551 | Afrin 0.025 % Nasal Spray | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2606775 | dimethicone propyl PG-betaine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2606776 | hydrogenated polydecene (3100 CST) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2606777 | isostearyl sebacate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2606778 | phosphatidylcholine:ceramide cholinephosphotransferase 1 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2606779 | zonisamide 20 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2606780 | zonisamide Oral Liquid Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2606781 | zonisamide Oral Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2606782 | zonisamide 100 MG in 5 mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2606782 | zonisamide 100 MG in 5 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2606782 | zonisamide 100 MG in 5 mL Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2606783 | Zonisade | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2606784 | zonisamide 20 MG/ML [Zonisade] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2606785 | Zonisade Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2606786 | Zonisade Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2606787 | zonisamide Oral Suspension [Zonisade] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2606788 | ZONISADE 100 MG in 5 mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2606788 | ZONISADE 100 MG in 5 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2606788 | ZONISADE 100 MG in 5 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2606788 | ZONISADE 100 MG in 5 mL Oral Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2606838 | cevimeline hydrochloride 30 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2606840 | cevimeline hydrochloride 30 MG [Evoxac] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2606842 | magnesium chloride 0.3 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2606843 | potassium chloride 0.37 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2606844 | sodium acetate 2.22 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2606845 | sodium chloride 5.26 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2606847 | magnesium chloride 0.3 MG/ML / potassium chloride 0.37 MG/ML / sodium acetate 2.22 MG/ML / sodium chloride 5.26 MG/ML / sodium gluconate 5.02 MG/ML [Physiosol] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 260688 | povidone-iodine 100 MG/ML Douche [Betadine] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 260688 | povidone-iodine 100 MG/ML Douche [Betadine] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 260690 | Acid Jelly 0.92 % Vaginal Gel | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 260690 | Acid Jelly 0.92 % Vaginal Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 260690 | Acid Jelly 0.92 % Vaginal Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2607 |